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Abstract 
Proteins are thought to be degraded exponentially. That means that newly synthesized proteins have 
the same probability to be degraded as old proteins. However, evidence has accumulated showing 
that this is not true in all cases. To analyze this more systematically, we developed a method employing 
metabolic pulse-labeling by the non-canonical amino acid azidohomoalanine (AHA). AHA enables 
enrichment of newly synthesized proteins directly after pulse or after chase in AHA-free medium. We 
used SILAC and shotgun proteomics to quantify how much protein remains after different lengths of 
chase to create degradation profiles for thousands of proteins. Importantly, these degradation profiles 
allowed us to detect changes in degradation kinetics as the proteins age. We found that more than 10 
% of proteins are non-exponentially degraded (NED). These protein are exclusively stabilized by age. 
Proteasomal degradation of excess protein complex subunits seems to explain a large fraction of NED. 
Comparing NED in mouse and human cells, we found that NED is at least partially conserved, 
seemingly due to cells consistently making too much of certain subunits. These overproduced subunits 
are on average shorter and more structured than the exponentially degraded proteins within the same 
complex. Finally, since excess NED proteins are degraded during baseline conditions, we hypothesized 
that making more of a NED protein would not increase its steady state levels. We employed an 
aneuploidy cell model and found that indeed NED proteins encoded on trisomic chromosomes did not 
increase in steady state levels to the same extent as exponentially degraded proteins. Instead, we 
recorded an increase in initial degradation of these proteins. In summary, we present a method for 
global pule-chase experiments allowing the detection of age-dependent protein degradation with 
possible implications for the understanding of aneuploidy and cancer.     
 
 
Keywords: Azidohomoalanine, SILAC, pulse-chase experiments, non-exponential kinetics, protein 
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Zusammenfassung 
Es wird allgemein angenommen, dass Proteine exponentiell degradiert werden. Das bedeutet, dass 
neu synthetisierte als auch  alte Proteine mit gleicher Wahrscheinlichkeit degradiert werden. Es 
tauchen jedoch immer mehr Hinweise dafür auf, dass das nicht immer der Fall sein muss. Um diese 
Fragestellung systematisch anzugehen, haben wir eine Methode zur metabolischen Pulsmarkierung 
mit der nichtkanonischen Aminosäure Azidohomoalanine (AHA) entwickelt. AHA ermöglicht die 
Anreicherung von neu synthetisierten Proteinen direkt nach einem Puls oder nach einer „chase“ 
(Nachverfolgung) Periode in AHA freiem Medium. Wir kombinierten diese Methode mit SILAC und 
Shotgun Proteomik um zu quantifizieren wieviel Protein nach verschiedenen chase-Perioden übrig 
bleibt. Damit konnten wir Degradationsprofile für tausende von Proteinen erstellen. Diese erlauben 
uns Veränderungen in der Degradationskinetik von alternden Proteinen zu ermitteln. Unsere Daten 
zeigen, dass mehr als 10 % der Proteine nicht exponentiell degradiert werden (NED). Diese Proteine 
werden mit fortschreitendem Alter ausschließlich stabiler. Proteasomale Degradation von 
überschüssigen Proteinkomplexuntereinheiten scheint einen Großteil der NEDs zu erklären. Beim 
Vergleich zwischen murinen und humanen Zellen stellte sich heraus, dass NED teilweise konserviert 
ist. Das liegt scheinbar daran, dass diese Zellen trotz unterschiedlichem Ursprungs einheitlich 
bestimmte Untereinheiten überproduzieren. Diese sind im Durchschnitt kürzer und strukturierter als 
exponentiell degradierte Proteine aus dem gleichen Proteinkomplex. Da überschüssige NED Proteine 
bereits unter  Standardbedingungen degradiert werden, nahmen wir an, dass die zusätzliche 
Überproduktion eines NED Proteins seine Level im stationären Zustand nicht verändern sollte. Um 
dies zu zeigen, quantifizierten wir Degradationskinetiken von Proteinen einer aneuploidenZelllinie. 
Wir fanden, dass NED Proteine, die auf trisomischen Chromosomen codiert sind, nicht in gleichem 
Maße ihr stationäres Level steigerten wie exponentiell degradierte Proteine. In Übereinstimmung mit 
unserer Hypothese verzeichneten wir stattdessen eine Zunahme der anfänglichen Degradationsraten 
dieser NED Proteine. Zusammenfassend ist eine Methode für globale Pulsmarkierung zur Analyse von 
altersabhängiger Proteindegradation mit möglichen Anwendungsgebieten bei Aneuploidie und Krebs 
vorgestellt.  
 
Keywords: Azidohomoalanine, SILAC, pulse-chase, Nicht Exponentiell Degradationskinetik, Proteine 
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Statement of Contributions 
The work presented in this thesis is built on a collaborative effort. Many people were involved at 
different stages of the project. As a common example, I suggested that we model the number of data 
points that was required to define a NED protein, Matthias Selbach suggested a boot strap approach 
which was applied by Celine Sin and finally a figure (Figure 23) was produced by Henrik Zauber. 
However, as a rule of thumb it’s good to know that the main idea (using AHA p-c to investigate non-
exponential degradation) came from Matthias Selbach and most of the further developments were 
conjured in collaboration between him, Henrik Zauber and myself with the clear exceptions 
mentioned below. In addition, most wet lab work was performed by myself, once again with the 
exceptions below. To avoid confusion I have below outlined the individual contributions. For clarity I 
have also annotated the figure legends and respective material and methods segments with whom or 
by whom the work was performed.  
Celine Sin and Angelo Valleriani, both at the MPI for Colloids and Interfaces, performed and 
developed the Markov-chain modeling see Figure 20 (script by Celine Sin), Figure 21 and Figure 22 for 
examples. Based on a suggestion to use the most stable proteins as normalization factors, Celine Sin 
also created and applied the elegant LSD normalization algorithm (see Figure 18). Both these steps are 
integral to analyzing the AHA p-c data. This is further exemplified by the fact that most of the data in 
the supplemental tables 1, 2, 4 and 5 is the direct output from their analysis.   
Henrik Zauber performed much of the bioinformatic analysis presented in the thesis. He performed 
the computational analysis in and created Figure 16, Figure 22-24, Figure 26, Figure 27 E-F, Figure 29 
A-D, Figure 35, Figure 37-38, Figure 42-43 and Figure 45. He also developed and implemented the 
complex centric analysis (Figure 33 B-C, Figure 39 and Figure 44) and distinguished ED and NED related 
properties using ROC analysis (Figure 30). 
Joseph A. Marsh and Jonathan N. Wells (University of Edinburgh) performed the complex enrichment 
and complex assembly analysis and created Figure 31 A and Figure 32. 
Neysan Donnelly and Zuzana Storchova (MPI for Biochemistry) produced the RPE-1 Cell lines, 
performed chromosome paintings (Figure 41 B) and sample preparation for whole genome 
sequencing (Figure 36 and Figure 41).  
Xi Wang, Jingyi Hou and Wei Chen (all MDC) performed whole genome sequencing and corresponding 
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1 Introduction 
Protein degradation is a vital biological process which is involved in most cellular functions. In this 
introduction I will discuss the major concepts related to protein degradation. Known functions of 
protein degradation and the main molecular mechanisms responsible for it will be introduced. First, I 
will present a summary of the historical advancement in the field. Second, I will present the open 
questions this thesis is focused on. Third, I will present our approach to answering these questions. 
1.1 A short history of protein degradation 
In this historical review I hope to emphasize some facts: 
 Protein degradation is not one but many coexisting, highly regulated and complex processes 
 Proteins are degraded for a multitude of reasons, ranging from regulatory mechanisms, 
release of free amino acids during starvation to “quality control” of faulty proteins  
 Technical advancements have been key for understanding these biological processes 
 Kinetics of protein degradation are more diverse than exponential degradation  
1.1.1 Until 1905: The early days 
The term protein, derived from Greek meaning “of the first rank”, was coined by Berzelius in 1838 for 
a set of important body constituents consisting of a consistent set of chemicals (Hartley, 1951; Mulder, 
1838). At the time of Berzelius only four proteins were known: albumin, fibrin, gelatin and casein 
(Reynolds, 2001; Vickery, 1950). These proteins were thought to exist in both animal and plant bodies 
but to be made exclusively by plants; animals subsequently needed to eat plants to take up proteins 
(for review see (Vickery, 1950)). However, what happened with proteins in the animal body was a 
mystery. How were proteins metabolized and used for energy and catabolic processes? 
About one hundred years after the discovery of urea as “the native salt of the body” von Liebig 
suggested that nitrogen in urine might be taken as a measure of protein destruction (Boerhaave, 1732; 
Lusk, 1909 ; von Liebig, 1842). This idea was confirmed by von Voit, who measured nitrogen content 
in meat consumed by a dog and correlated this with the levels of nitrogen in the urine and feces from 
the dog (Lusk, 1909 ; von Voit, 1860). In addition, polypeptides had been shown to be digested in vitro 
by purified digestive enzymes such as trypsin and pepsin (McCance, 1930). It therefore seemed 
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Nevertheless, where in the body proteins were degraded remained an open question. There existed 
two distinct hypotheses. The first was put forward by von Voit who suggested that proteins in the 
blood rarely became a part of cells but were mainly used as an energy source (Folin, 1905b). In 
contrast, Pflüger proposed that ingested proteins became an integral part of the cells and then 
degraded (Folin, 1905b; Pflüger, 1893).  
1.1.2 1905 - 30: The Folin hypothesis 
Folin strongly opposed the intracellular degradation hypothesis because of “the well-known fact that 
extremely large quantities of food protein are more or less completely katabolized in the course of a 
few hours. It is considered incredible that such enormous building up of bioplasm, accompanied by 
immediate destruction of it, can take place in so short a time” (Folin, 1905b). Instead he put forward 
his own hypothesis based on his experimental measurements of urine content of a normal (July 13. 
Figure 1) and protein starved man (July 20. Figure 1). He found that protein starvation led to a strong 
change in the composition of urine. For example, the urea content strongly dropped whilst the 
kreatinin levels where unchanged. “To explain such changes in the composition of the urine on the 
basis of protein katabolism, we are forced, it seems to me, to assume that katabolism is not all of one 
kind. There must be at least two kinds.” (Folin, 1905b). Folin continues to distinguish between the low 
endogenous metabolism, for wear and tear, and the larger exogenous metabolism, for energy 
consumption. Folin’s hypothesis became dominant at the time and a consensus idea of protein 
turnover in mammals had emerged (McCance, 1930). 
 
 
Figure 1. Protein starvation does not uniformly change the composition of urine.  
Urine composition of a “normal person” on two different diets: milk and egg (July 13) and Starch and 
cream (July 20). Note that the absolute amount of kreatinin stays constant even though the total 
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1.1.3 1930 – 45: Rudolph Schönheimer  
In 1936 Schönheimer had fed mice deuterated fatty acids and measured their degradation rates in a 
study that deployed concepts like “turnover” and “half-life time” of a body constituent for the very 
first time (Ratner, 1979; Schoenheimer and Rittenberg, 1936). Schönheimer continued his work by 
deploying enriched heavy nitrogen (15N) isotopes (Urey and Greiff, 1935; Urey, 1937). From these 
heavy labeled amino acids were synthesized and fed to rats (Schoenheimer and Ratner, 1939). Urine 
was collected and body tissues were harvested at different time points and the heavy and light 
nitrogen bound in different molecules were measured on a Bleakney type mass spectrometer 
(Bleakney, 1929). Analyzing the results it became obvious that Folin’s theory was wrong. 50 % of the 
administered DL-tyrosine was retained in the body of the rat and even higher values were later 
measured for the L-isoform (Schoenheimer et al., 1939). Further deploying his techniques, 
Schönheimer was able to investigate the turnover of individual protein species. He and Ratner 
followed the synthesis and degradation of antibodies created after active (by vaccination) or passive 
(by injection of antibodies) immunization of rats (Figure 2) (Heidelberger et al., 1942). The antibodies 
could then be enriched by the antigen and their turnover measured (Ratner, 1979). The actively 
immunized antibodies were turned-over and a turnover rate could be calculated (Heidelberger et al., 
1942). Schönheimer had thereby opened up the possibility to measure protein degradation kinetics. 
 
Figure 2. The first turnover measurement for an individual protein. 
Abundance of 15N in antibodies from actively (type III) and passively (Type I) immunized rats. 
Antibodies from passively immunized (i.e. injected with antibodies) rats do not incorporate 15N. 
Antibodies from actively immunized rats do incorporate 15N. When the heavy isotope glycine diet is 
removed, the 15N containing antibodies are degraded and a turnover rate can be calculated (not 
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1.1.4 1945 – 75: The era of the lysosome and radioactive tracers 
1.1.4.1 Long-lived radioactive isotopes open up the field of degradation kinetics 
The existence of long-lived radioactive isotopes of atoms contained in organic matter was long 
questioned (Kamen, 1985). The few radioactive isotopes known all had half-lives too short for most 
biological experiments e.g. 15O has a half-life of 2 min (See Figure 3 for a discussion on exponential 
decay). However, when 14C (half-life 5730 years) was discovered in 1939, the radioisotope was quickly 
employed (Borsook et al., 1950; Ruben, 1941). Similarly, 35S (half-life 88 days) was properly described 
in 1940 (Levi, 1940). 35S L-Methionine and L-Cysteine could be synthesized in bulk by 1952 (Williams 
and Dawson, 1952). The cumbersome methods employing stable isotopes by Schönheimer, which 
required a hand built mass spectrometer, were then quickly abandoned.  
Discussion arose surrounding Schönheimer’s findings when data showed that exponentially growing 
bacteria displayed almost no protein degradation when pulsed with radioactive amino acids (Hogness, 
1955). The authors suggested that the “dynamic state of body constituents” was merely an effect of 
protein secretion and cell lysis in the complex mammalian organs. The results gained traction because 
of the well-controlled model system where cell lysis could be accounted for. However, the 
controversies were later resolved when results were published demonstrating protein turnover in E. 
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Figure 3. Radioactive isotopes display exponential decay. 
By definition the number of radioactive isotopes (red dots) remaining will decrease by half for each 
half-life time (t1/2) that passes. If one plots the number of molecules remaining over time in a semi-
exponential plot, it will result in a straight line (upper right panel). However, if one looks at the decay 
probability for each individual radioactive isotope, it is constant with a 50 % probability over the next 
half life time. In other words, the decay probability is constant over the age of the molecules (lower 
right panel). This means that a newly created “young” radioactive isotope has the very same decay 
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1.1.4.2 Robert Schimke and the regulation of protein degradation 
To study the function of protein degradation Schimke first focused on the final enzyme in the urea 
cycle, arginase, which converts arginine into urea and ornithine (Schimke, 1964). Schimke applied 14C 
labeling in rats during different dietary regimes in combination with biochemical and immunological 
purification of arginase. It became clear that during starvation degradation of the enzyme stopped, 
increasing the arginase steady state levels, and conversely, after a change from high to low protein 
diet, the degradation rate of arginase increased. He went on to show that administration of 
tryptophan increased the synthesis rate and decreased the degradation rate of the enzyme 
tryptophan hydrolase (Schimke et al., 1965). These two studies led to a paradigm shift because until 
then protein degradation was thought to be passive and dependent on the inherent stability of the 
proteins. Importantly, Schimke´s findings created a rationale behind the continued turnover of 
proteins in the sense that degradation rates could correlate with the ability to adapt to stimuli. For 
example, the 12 liver proteins with the shortest half-lives were responsible for the rate limiting steps 
in their respective biochemical pathway (Goldberg and Dice, 1974). They could therefore be quickly 
up or down-regulated.    
1.1.4.3 The discovery of lysosomes by Christian de Duve  
The discovery of the lysosome by Christian de Duve was a result of a failed attempt to localize the 
enzyme glucose-6-phosphatase within the cell (Duve, 1975). De Duve applied the recently developed 
differential centrifugation technique to homogenized rat liver to distinguish between distinct cellular 
organelles (Claude, 1946). He found that 95 % of the glucose-6-phosphatase was localized in the 
microsomal fraction. As a control he assayed for the activity of acid phosphatase in the mitochondrial 
fraction but found only 10 % of the expected activity based on previous measurements using harsher 
centrifugation techniques (reviewed in (Bainton, 1981)). However, when the samples where 
reassessed a few days later, all of the expected activity was recovered. The latent activity of the 
enzyme was attributed to the breakdown of a membrane that previously prevented the accesses of 
substrate to the enzyme. Further biochemical analysis revealed that the enzyme was not located in 
mitochondria but rather in a distinct compartment. A number of proteases with differing substrate 
specificities but with their highest activity at low pH were also found to be located in this new 
membrane enclosed compartment (Bainton, 1981). The potential function in cellular degradation 
processes lead to the naming of the organelles as lysosome (De Duve et al., 1955). The cellular function 
of lysosomes was quickly investigated (see Figure 4 for a modern understanding of lysosomal 
function). For example, Werner Straus and colleagues showed that lysosomes could be responsible 
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others later showed that cells also could degrade internal proteins, a process he termed autophagy 











Figure 4. Principles of Autophagy. 
Today it’s believed that lysosomes mainly play a role in cell maintenance by clearing larger organelles 
(i.e. mitochondria) especially after cell stimuli (e.g. starvation or growth factor deprivation) and in 
degradation of endocytosis products (Castro-Obregon, 2010). Autophagy is the process in which 
autophagosomes (yellow background) engulf intracellular molecules and organelles such a 
mitochondria (Takeshige et al., 1992). They then fuse with protease containing organelles called 
lysosomes (red background). The combined organelles, referred to as autolysosomes, are acidified, 
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1.1.4.4  Degradation of “abnormal” proteins 
“There must exist strong selective pressure favoring the evolution of a mechanism to degrade 
abnormal protein, since the intracellular accumulation of inactive or partially active enzymes 
should be highly deleterious” – (Goldberg, 1972). 
In 1974, Alfred Goldberg and Fred Dice summarized the current understanding of the physiological 
function of protein degradation (Goldberg and Dice, 1974). They outlined three main purposes for 
protein degradation: 
1. Based on Schimke's findings it was clear that degradation rates were used by the cells to 
rapidly change the concentration of an enzyme  
2. Starvation induced degradation to increase the pool of free amino acids  
3. Quality control of abnormal proteins 
Goldberg was a strong champion of the third option and he and others had previously shown that 
anomalous proteins were rapidly degraded in E. coli and reticulocytes (Goldberg, 1972; Pine, 1967; 
Rabinovitz and Fisher, 1964). For example, premature translational termination, by the addition of 
puromycin, led to unfinished polypeptides rapidly being degraded (Goldberg, 1972). In addition, 
increasing translation error rate by using an E. coli strain with a ribosomal mutation lead to amplified 
protein degradation (Goldberg, 1972). These and other findings clearly demonstrated that protein 
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1.1.4.5 Exponential degradation as the dominant model of protein removal  
 “Where it has been studied carefully, the breakdown of enzymes obeys first order kinetics, 
which means that newly synthesized proteins are as likely to be degraded as old ones. In other 
words, degradation of polypeptides is a random event unlike aging of organisms or red cells.” 
– (Goldberg and Dice, 1974).  
That quote and similar claims by Schimke laid the foundation to the nowadays common assumption 
that all proteins are exponentially degraded (Schimke and Doyle, 1970). It is worth noting that at the 
time two examples of non-exponentially degraded proteins were known. The above mentioned 
haemoglobin was degraded in concert with the rest of the red blood cell (Shemin, 1946). Red blood 
cells are disposed of in an age-dependent manner by the liver since they lack most mechanism of self-
repair. Similarly, the proteins of the outer rod cells are stable until a certain age when they are 
displaced and degraded (Figure 5, (Young and Bok, 1969)). Nevertheless, an exponential assumption 
was to accompany the degradation field for decades to come. 
 
Figure 5. An example of age-dependent destabilization. 
A) Illustration of findings from (Young and Bok, 1969). Black dots indicate location of radioactive 
proteins in rod cells. First rod cell (from the left) shows the localization minutes after injection of L-
methionine-3H into frogs. The newly synthesized proteins are then organized in a disc shape (second 
rod cell from the left). The discs are gradually displaced by newer discs. After about 6 weeks the disc 
disappears and is phagocytosed by pigmented epithelial cells. B) Graphical representation of the 
stability of the disc proteins (note the time scale). They show a clear non-exponential profile in which 
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1.1.5 1975-2000: the proteasome and spatial distribution of cellular degradation 
1.1.5.1 The ubiquitin-proteasome system  
Many lines of evidence were accumulating indicating that a second cellular degradation system must 
exist (for discussion see: (Ciechanover, 2005)). For example: 
I. There existed large differences in protein half-lives inconsistent with the slow process of 
autophagy 
II. Lysosomal inhibition did not stop degradation of short-lived or abnormal proteins 
III. Most protein degradation required energy in contrast to the exergonic lysosomal processes  
For the discovery of the proteasome a certain cell system was required: the reticulocytes. These 
immature red blood cells lack lysosomes but could nevertheless degrade abnormal proteins 
(Rabinovitz and Fisher, 1964). Goldberg isolated the system and demonstrated that it degraded 
proteins in vitro in an ATP-dependent manner at neutral pH (Etlinger and Goldberg, 1977). Hershko 
and Chiechanover further worked out the details and showed by fractionating cell lysates that the 
system required at least two components (Ciehanover et al., 1978). They focused on the first fraction 
and demonstrated that it contained a small protein they named APF-1 (ATP-dependent proteolysis 
factor 1). APF-1 was found to be covalently linked to the protein substrates which were degraded 
when incubated with the second fraction (Ciechanover et al., 1980b; Hershko et al., 1980). A model 
was proposed in which APF-1 was conjugated to the substrate and targeted it for degradation. 
Afterwards APF-1 would be released and reused. APF-1 was soon shown to be the previously described 
protein ubiquitin (Ciechanover et al., 1980a; Wilkinson et al., 1980). Ubiquitin was shown to be 
conjugated to other proteins by isopeptide linkage to a lysine (Goldknopf and Busch, 1977; Hunt and 
Dayhoff, 1977). Soon after the 20S and 26S proteasome were purified and a coherent model of specific 
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Figure 6. Principles of the ubiquitin-proteasome system.  
An E1 ubiquitin-activating enzyme attaches an ubiquitin molecule to an E2 ubiquitin-conjugating 
enzyme (E2) in an energy-dependent fashion. The E2 then binds to an E3 ubiquitin ligase. The E2/E3 
combo then specifically recognizes certain protein substrates and attaches the ubiquitin to a lysine 
residue. Repeated cycles of ubiquitination take place until a poly-ubiquitin chain has formed. The poly-
ubiquitin chain is then recognized by the proteasome and the substrate is guided into the barrel-
shaped 20S core particle. Inside the proteasome multiple specific protease activities work on the 
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1.1.5.2 ER associated degradation (ERAD) 
The endoplasmic reticulum (ER) is a large membrane-enclosed organelle organized in a network-like 
configuration (Porter et al., 1945). Two forms, rough and smooth, of the ER are usually recognized. 
The rough ER gets its appearance from the multiple ribosomes associated to the outside of the 
membrane. Accordingly, the ER is a place where newly synthesized proteins mature, e.g. fold and are 
post-translationally modified (Meusser et al., 2005). Specifically, those proteins that will be secreted 
or exposed on the cell surface are co-translationally or translocated directly after translation into the 
ER (Jan et al., 2014). The proteins are transported via the Golgi apparatus before finally being exported 
or inserted in the cell membrane.   
A quality control system associated with the ER was long predicted because of the numerous examples 
of proteins being synthesized into the ER and subsequently degraded. One main group of proteins 
degraded was non-assembled protein complex subunits. For example, subunits of the 
Asialoglycoprotein receptor (Amara et al., 1989), T-cell receptor (Chen et al., 1988; Lippincott-
Schwartz et al., 1988), Gonadotropin hormone dimer (Corless et al., 1987), IgM complex (Dulis et al., 
1982), Acetylcholine receptor (Merlie et al., 1982) and Fibrinogen (Plant and Grieninger, 1986). The 
degradation of many of the examples was shown to be dependent on a posttranslational modification: 
the addition of a carbohydrate in a processed called glycosylation.  
Another ER-contained protein, cystic fibrosis transmembrane conductance regulator (CFTR), helped 
bring clarity into the degradation mechanism (Jensen et al., 1995; Ward et al., 1995). CFTR that lacked 
a phenylalanine at position 508 was known to misfold and be thereafter rapidly degraded from the 
ER. With the recently developed proteasome inhibitors (e.g. MG132 (Goldberg, 2012; Rock et al., 
1994) and lactacystin (Fenteany et al., 1995)) it became possible to show that the ER-residing proteins 
were in fact degraded by the proteasome (Jensen et al., 1995; Ward et al., 1995). However, no 
proteasomes are located in the ER, so ER-residing substrates needed to be retro-translocated back 
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Figure 7. Overview of ER-associated degradation (ERAD).   
Newly synthesized proteins are translocated into the ER through a multiprotein channel as unfolded 
polypeptides (Jan et al., 2014). In the ER the proteins have their ER-targeting signal sequence cleaved 
off (if present), are folded with the help of heat shock proteins, have disulfide bonds created by 
oxidoreductases and are modified by covalent attachment of complex sugars to asparagine residues 
by the oligosaccharyltransferase (Buchberger A, 2010; Mandon et al., 2013). These sugars moieties 
are further modified leading to a “glyco-code” which is read by lectins, which direct the proteins to 
ER-exit, refolding or ERAD (Aebi et al., 2010). When ERAD is selected, proteins are exported out of the 
ER via a translocon while simultaneously being poly-ubiquitinated by ER-associated E3 ubiquitin ligase 
Hrd1. The poly-ubiquitinated protein is recognized by the AAA-ATP p97/VCP that extracts the protein 
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1.1.5.3 Non-exponential degradation and ER associated degradation  
Interestingly, many of the endogenous ERAD substrates discussed above, such as the T-cell receptor 
subunits (Lippincott-Schwartz et al., 1988) and CFTR (Ward and Kopito, 1994), are non-exponentially 
degraded since they are targeted for degradation mainly before they assemble (TCR) or fold (CFTR) 
and then become stable when they reach the cell surface. Another interesting example is Basigin 
(Figure 8). This protein is, similarly to the TCR and CFTR, synthesized into the ER, where it matures, 
and when assembled is transferred to the cell surface. Interestingly, the unassembled core-
glycosylated form has a half-life of about 90 minutes while the cell surface exposed protein is stable 









Figure 8. Basigin is a non-exponentially degraded protein. 
A) Basigin is synthesized into the ER as a lower molecular weight protein (140 kDa). As time passes, 
the protein becomes glycosylated in the ER and shows up with a heavier molecular weight (160 kDa). 
Interestingly, only a fraction of the newly synthesized proteins, ~20 %, survive the transition. The 
mature protein, however, is strikingly stable. Reproduced (and modified) with permission from (Tyler 
et al., 2012). B) A schematic plot of what the data in A) would look like in a semi-logarithmic plot. This 
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1.1.6 2000 – Current: Global measurements  
1.1.6.1 Kinetics of degradation – not so exponential after all 
A commonly applied method in the 70s and the 80s was the double labeling technique. For example, 
cells could be labeled for a longer time period with 14C followed by a shorter labeling period with 3H. 
The result of this technique was the selective labeling of a long-lived and short-lived protein 
population (e.g. (Poole and Wibo, 1973)). In 1980, Wheatly and colleagues criticized the interpretation 
of the two population of proteins: “The technique of selectively labeling ‘short’ and ‘long-lived’ 
proteins, which implies qualitative differences between them, is more readily interpreted as an artificial 
polarisation of a declining statistical probability curve of proteolysis with time which is similar for all 
nascent proteins” (Wheatley et al., 1980). In other words, they proposed that the suggested two 
populations of distinct proteins with different life expectancies could equally well be explained by one 
population of proteins that become more stable over time.  
One explanation of why a cell would seemingly wastefully degrade a significant proportion of new 
proteins was proposed by Yewdell, Anton and Bennink (Yewdell et al., 1996). They proposed that short 
lived proteins were defective ribosomal products (DRiPs). Peptides from the DRiPs were used for 
presentation on MHC-I molecules on the cell surface allowing CD8+ T cells to distinguish between self 
and none-self (Rock and Goldberg, 1999). This mechanism, they claimed, could explain how cells could 
respond so rapidly to viral infections, before the viral proteins were a significant part of the 
intracellular protein pool, and also why it was so hard for viruses to avoid cell surface exposure of their 
proteins. A significant boost to this theory was gained when a paper describing the results of very 
short 35S Methionine pulses (30 seconds) followed by chases up to 60 minutes using HeLa cells was 
published (Schubert et al., 2000). The pulses were performed with or without proteasome inhibitors. 
In the presence of inhibitor roughly 30 % more labeled proteins were recovered. This led to the 
conclusion that ~30 % of all newly synthesized protein were directly degraded. This number was, 
however, soon questioned when it was shown that protein synthesis is dependent on proteasome 
function during amino acid starvation (Vabulas and Hartl, 2005). In other words, part of the increase 
in radioactive-labeled proteins reported by Schubert et al. could be explained by a more severe amino 
acid starvation and therefore more efficient loading of tRNA with radio-labeled amino acids, in the 
presence of proteasome inhibitor. The new investigation limited the amount of proteins rapidly 
degraded to a few percent on a global level. To date, the question of whether protein turnover can 
explain the MHC class-I peptidome without assuming degradation of DRiPs is still open (Bassani-
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In contrast, the existence of non-exponential protein degradation is well backed up. Recently, studies 
focusing on co-translational ubiquitination and degradation have been published (Duttler et al., 2013; 
Pechmann et al., 2013; Wang et al., 2013). They concluded that ~15 % (in human) and >1 % (in yeast) 
of nascent polypeptides are co-translationally ubiquitinated and targeted to the proteasome. Another 
line of evidence was derived from enriching ubiquitinated peptides in combination with dynamic SILAC 
(Kim et al., 2011). This study showed that ubiquitinated proteins were consistently younger than the 
non-ubiquitinated proteins. They further showed that the ubiquitination was increased by blocking 
the proteasome, strongly suggesting that the young ubiquitinated proteins were targeted for 
degradation. 
1.1.6.2 Global turnover measurements: dynamic SILAC 
Although modern 15N labeling and stable isotope labeling by amino acids (SILAC) as developed by the 
Mann group both share many features with the pioneering work of Schönheimer, there have been 
some major developments, mainly on the mass spectrometric and computational side (Ong et al., 
2002). I will here only discuss the most common approach for proteomics referred to as shotgun 
proteomics. In shotgun proteomics, digested proteins are detected and quantified by liquid 
chromatography coupled to tandem mass spectrometry (LS-MS/MS) and then computationally 
reassembled (Cox and Mann, 2008; Zhang et al., 2013). This method has successfully been employed 
to measure the abundance of many cellular proteomes with near complete coverage (de Godoy et al., 
2008; Nagaraj et al., 2011). Using label free methods it is possible to measure differences between 
samples with high accuracy (Cox et al., 2014). However, when combined with stable isotope labeling, 
relative quantification within samples is greatly improved (Ong et al., 2002; Wu et al., 2004). Although 
15N labeling is cheap and suitable for measuring protein turnover, the vast amount of nitrogen in 
proteins and the less than 100 % pure enrichment of heavy nitrogen isotopes make most peptides 
only partially labeled, impairing both identification and quantification. 15N is therefore mainly used for 
labeling organisms that synthesize all their own amino acids, like plants, or when large amounts of 
labeled amino acids would be required, such as when labeling rats (Toyama et al., 2013; Wu et al., 
2004).  
Dynamic SILAC is based on changing some amino acids in cell culture medium (or food when labeling 
animals) from light to heavy versions (Doherty et al., 2009; Krüger et al., 2008; Sheean et al., 2014). 
By taking samples over time and measuring the heavy to light ratio one can calculate the turnover of 
the proteins, at least if the cell doubling time is known. This type of measurement lead to the ability 
to acquire global knowledge of turnover rates on a proteome-wide scale (Doherty et al., 2009; 
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protein dynamics (Andersen et al., 2005; Lam YW, 2007). By combining SILAC pulse labeling with 
subcellular fractionation, the authors showed that ribosomal proteins are rapidly shuffled into the 
nucleolus, where they combine with cofactors and rRNA to form the small and large ribosomal 
subunits. This process was measured to take on average 2 hours before ribosomes were exported out 
to the cytoplasm. Interestingly, a large part of the newly synthesized proteins were found to be 
degraded in the nucleus, in stark contrast to the very stable cytoplasmic version of the same proteins 
(Lam YW, 2007). 
1.1.6.3 State of the art - Methodological limitations for protein kinetics research 
Dynamic SILAC labeling is limited by the fact that the pre-existing light proteins are still present. That 
means that if a protein is turned over slowly the relative amount of newly synthesized proteins will be 
drowned out by the massive signal from the pre-existing light proteins. Thereby, the minimal pulse 
times for a good signal to noise for most protein are in the range of multiple hours for mammalians 
cells (Schwanhäusser et al., 2011). In addition, most calculations that are used to calculate turnover 
are based on an assumption of exponential degradation (Christiano et al.; Hinkson and Elias, 2011; 
Schwanhäusser et al., 2011). Therefore, the currents methods are sufficient to measure steady state 
degradation rates and changes of these between cell types or between control and treated cells. 
However, to enable measurements of changes in degradation kinetics for the same protein as it “ages” 
would require pulse-chase experiments. It is by following proteins with a limited age-distribution that 
one can untangle differences in degradation rates. Therefore, the long pulse-times required for 
dynamic SILAC are not suitable for global kinetic measurements (Hinkson and Elias, 2011; Larance and 
Lamond, 2015). Other methods, such as global protein stability profiling, bleach-chase or tandem 
fluorescent timers that rely on fusing protein with fluorescent tags, suffer from similar shortcomings 
(Eden et al., 2011; Khmelinskii et al., 2012; Yen et al., 2008). The current gold standard of pulse-chase 
experiments are still performed using radioactive labeling coupled to immunoprecipitation. This 
methodology does not easily lend itself to multiplexing, which usually limits the analysed proteins to 
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1.2 This study 
1.3 Are all proteins exponentially degraded?  
Reviewing past research it becomes clear that the hypothesis of exponential degradation as put 
forward by, among others, Schimke does not hold true for all proteins. However, the fraction of the 
proteome that is non-exponentially degraded (NED) is to date not known. In other words, are the 
examples known so far just ad hocs for specific circumstances or is NED common? 
This thesis will try to answer the following questions: 
1. How common is NED? 
2. Do NED proteins become more or less stable with age? 
3. What proteins are NED? 
4. What are the molecular mechanisms involved? 
5. What are the biological implications of NED? 
1.4 How to study NED on a global level 
To study kinetics of protein degradation an age-defined population of proteins with a limited age-span 
is needed. Degradation from this population then needs to be followed over time. If one plots the ”% 
protein remaining” in semi-log space over time, one would expect the data points to lay on a straight 
line if the protein is exponentially degraded (e.g. see Figure 3). If the data points are not falling on a 
straight line, the proteins do not follow first order degradation kinetics (for example Figure 5 and 
Figure 8). In this thesis we introduce a method that allows for all these types of measurements on a 
global level.   
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2 Materials and Methods 
2.1 Cell lines 
NIH 3T3 mouse fibroblast cells  
From ATCC. 
Human retinal pigmented epithelial cells (RPE-1)  
The cell line RPE-1 immortalized with hTERT (referred to as RPE-1) was a kind gift from Stephen 
Taylor (University of Manchester, UK) and described in detail in Stingele et al. (2012). 
RPE-1 trisomic cells 
The derivative cell line RPE-1 5/3 11/3 12/3 (referred to as RPE-1 trisomic) was generated using 
microcell-mediated chromosome transfer in Stingele et al. (2012). The partial trisomy of 
chromosome 11 spontaneously occurred and is unique to this study.  
Cell culture for the different cells lines is described under the individual experiment sections.  
2.2 Experiments using mouse cells 
2.2.1 Dynamic SILAC to determine effects of AHA on protein synthesis 
NIH 3T3 mouse fibroblast cells were grown in 6-well plates in SILAC DMEM (Life Technologies) 
complemented with glutamine (Glutamax, Life Technologies) and 1 % Penicillin and Streptomycin (Life 
Technologies), 10 % dialyzed fetal calf serum (dFCS, Pan-Biotech), light L-arginine (Arg0, Sigma-Aldrich) 
and light L-lysine (Lys0, Sigma-Aldrich) referred to as Light SILAC DMEM (Ong et al., 2002). When the 
cells reached 30 % confluency they were starved in Light DMEM depleted of methionine (Biosera Ltd). 
After 1 h the cells were switched to Heavy SILAC DMEM medium containing heavy L-arginine (Arg10, 
Sigma-Aldrich) and heavy L-Lysine (Lys8, Sigma-Aldrich) and supplemented with different 
concentrations of azidohomoalanine (AHA, Anaspec) and/or methionine (Sigma-Aldrich) as shown in 
the figure. After a 4 h the cells were washed and lysed in modified RIPA buffer (50 mM Tris (pH8), 
150 mM NaCl, 0.1 % SDS, 0.5 % sodium deoxycholate, 1 mM EDTA, 1 % NP40) with nuclease 
(Benzonase, Sigma-Aldrich) and 2-fold protease inhibitor cocktail (Roche) added. Lysates were 
incubated on ice for 10 minutes before being sonicated in an ice-bath for another 10 min. Proteins 
were precipitated by Wessel-Flügge precipitation (Wessel and Flugge, 1984). In short, proteins were 
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precipitated to get rid of SDS by sequentially adding methanol, chloroform and then water before 
spinning down the samples at 10,000 rcf and finally adding methanol again (Puchades et al., 1999; 
Sheean et al., 2014). After centrifugation, the retrieved protein pellet was resuspended in 6 M Urea, 
2 M Thiourea in 10 mM Hepes (pH8). Proteins were digested with Lysyl endopeptidase (LysC, Wako 
Chemicals) before being diluted in 50 mM ammonium bicarbonate (ABC) buffer and trypsinated 
(Invitrogen) overnight. The peptide solution was acidified by addition of TFA before peptides were 
desalted and stored on StageTips (Rappsilber et al., 2003). StageTips were prepared by putting 3 discs 
of C18 (3M) in 200 µL pipette tips and activating the material with methanol. Organic solvents were 
washed away by Buffer A (5 % acetonitrile and 0.1 % formic acid) before peptides were loaded onto 
the stageTip. Salts were washed away with Buffer A. Peptides were eluted using Buffer B (80 % 
acetonitrile and 0.1 % formic acid) and acetonitrile was evaporated in a speedvac (Eppendorf). 
Samples were diluted in Buffer A and peptides were separated on a 15 cm long column with 75 µm 
inner diameter packed in house with ReproSil-Pur 120 C18-AQ 3µm resin (Dr. Maisch GmbH) using a 
3 h linear gradient with 250 nl/min flow rate of increasing concentration of Buffer B in a High Pressure 
Liquid Chromatography (HPLC) system (ThermoScientific). Peptides were ionized by an electrospray 
ionization (ESI, ThermoScientific) source and analysed on a LTQ Orbitrap Velos mass spectrometer 
(ThermoScientific). The mass spectrometer was run in data-dependent mode selecting the top 20 
most intense ions in the MS full scans (Orbitrap resolution: 60,000; target value: 1,000,000 ions) for 
higher energy collision-induced dissociation. The resulting MS/MS spectra from the Orbitrap had a 
resolution of 17,500 with a target value of 5,000. The resulting raw files were analysed using 
MaxQuant software version 1.4.1.2 (Cox and Mann, 2008). Default settings were kept except that 
”match between runs“ was activated and ”reQuantify“ was turned off. Lys8 and Arg10 were set as 
labels and oxidation of methionines and n-terminal acetylation were defined as variable modifications. 
Carbamidomethyl of c-termini was set as fixed modification. The in silico digests of the mouse Uniprot 
database (2013-01) and a database containing common contaminants were done with Trypsin/P. The 
peptide- and protein-level false discovery rates were set to 1 % and were assessed by searching in 
parallel a data base containing the reversed mouse database sequences. Plotting was done in R version 
2.15.1 (R Foundation for Statistical Computing, Vienna, Austria). 
2.2.2 Enrichment efficiency of AHA-containing proteins 
NIH 3T3 cells were grown in Light SILAC DMEM. Confluent cells in 6-well plate wells were washed in 
pre-warmed PBS before being starved of methionine and cysteine for 45 min in DMEM depleted of 
methionine and cysteine (Invitrogen) with 10 % dFCS and 1 % penicillin and streptomycin added. Cells 
were then pulsed for 1 h with 80 µCi final concentration of 35S-Cysteine (Perkin Elmer) in combination 
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with either 1mM AHA or 1mM methionine. After the radioactive pulse, cells were washed in PBS and 
scraped in the same and pelleted by centrifugation. Cells were lysed and AHA-containing proteins 
covalently linked to alkyne beads using the “Click-it protein enrichment” kit (Invitrogen). In brief, cells 
were lysed in Urea lysis buffer (8 M Urea, 200mM Tris (pH 8), 4 % CHAPS and 1 M NaCl) supplemented 
with protease inhibitor cocktail (Roche) on ice for 30 min. Half the cell lysate was frozen and kept as 
input. Alkyne beads were prepared and copper-catalysed click reaction was performed as 
recommended by the manufacturer (Hou et al., 2015). Beads were washed twice in SDS wash buffer 
and supernatant was retained. The resulting three fractions: input, supernatant and beads, were 
added to 5 mL Rotiszint eco plus (Carl Roth) and measured by scintillation counting (Packard). The 
experiment was repeated twice and was analysed using Excel (Microsoft). 
2.2.3 Global 35S cysteine pulse-chase experiments 
Confluent NIH 3T3 mouse fibroblasts in 6-well plate wells were washed in pre-warmed PBS before 
being starved in methionine and cysteine free DMEM as above. Cells were then pulsed for 1 h with 80 
µCi final concentration of 35S-Cysteine (Perkin Elmer) in combination with either 1 mM AHA or 1 mM 
methionine. Cells were then washed twice in SILAC DMEM before either being directly lysed or chased 
for 6 or 24 h in cold medium with either 50 µM cycloheximide (Sigma-Aldrich) or 10 fold cysteine 
(Sigma-Aldrich) added to limit re-incorporation of radioactive amino acids. Finally, cells were scraped 
and lysed in modified RIPA buffer as above. All samples were frozen at -80 °C before being thawed on 
ice for 30 min in the presence of Benzonase. Samples were spun down to clear cell debris. The resulting 
supernatant was diluted in LDS sample buffer (Invitrogen) complemented with DL-dithiothreitol (DTT, 
Sigma Aldrich) before being boiled at 95 °C for 5 min. SDS-PAGE on a 10 % polyacrylamide gel was 
used to resolve proteins. In-gel fixation of proteins was accomplished by the addition of 5 % acetic 
acid and 50 % methanol. Proteins were labeled by Coomassie blue staining (colloidal blue stain kit, 
Novex). The gel was then vacuum-dried using a gel drying system (Bio Rad). To quantify total loaded 
protein, dried gels were scanned on a scanner (Canon). The radioisotope signal was measured by 
exposing the gel to a magnetic photo-stimulable phosphor-plate overnight. The plate was developed 
by a phosphorimager (Typhoon FLA 9500, GE Healthcare). ImageQuant software (GE Healthcare) was 
used to quantify radioactive and coomassie images. Each lane was quantified separately and 
background signal was estimated by quantifying an empty lane. The radioactive signal was then 
further normalized to total protein input estimated by the Coomassie staining. Three biological 
replicates with technical triplicates were performed. Statistics and plotting were performed in Excel 
(Microsoft). 
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2.2.4 Enrichment efficacy of AHA-labeled proteins 
NIH 3T3 mouse fibroblasts were cultured in a 10 cm plate in Heavy SILAC DMEM (life technologies) 
prepared as above. Cells were washed twice in pre-warmed Heavy SILAC DMEM depleted of 
methionine (Biosera) before being starved of methionine in the same for 1 h. The starvation was 
followed by a 2.5 h incubation with 1 mM AHA. The AHA-labeled Heavy cells were washed in ice cold 
PBS and then scraped in Urea lysis buffer containing two-fold protease inhibitors (Roche) and mixed 
1:1 with cells grown in Light SILAC DMEM. The lysate was treated with benzonase on ice for 20 min 
before being sonicated in an ice bath. A part of the lysate was saved to estimate mixing accuracy (see 
below). Samples were spun down at 20,000 rcf, the supernatant was transferred to a new tube 
containing alkyne agarose beads and the click reaction was performed overnight as described above. 
Proteins were reduced by heating to 70°C in the presence of 10 mM DTT in SDS buffer and later 
alkylated by the addition of 40 mM iodoacetamide (Sigma) final concentration. Beads were 
sequentially washed in SDS buffer, 8 M Urea in 100mM Tris (pH8) and 80 % acetonitrile by 
centrifugation and decanting supernatant. Proteins were digested “on bead” in 5 % acetonitrile in ABC 
buffer first 3 h with LysC and then overnight with trypsin. Input samples were Wessel-Flügge 
precipitated and “on-pellet” digested as above. 
Peptides were acidified and stageTipped as above. Eluted peptides were separated using HPLC and a 
4 h linear gradient with a 300 nl/min flow rate with increasing buffer B concentration. Peptides were 
passed over a 2 m long column with a 100 μm inner diameter containing monolithic C18 (kindly 
provided by Yasushi Ishihama (Kyoto University)). Peptides were ionized using an ESI source and 
analysed on a Q-Exactive mass spectrometer. The mass spectrometer selected the top 10 most intense 
ions in the MS full scans for higher energy collision induced dissociation and MS/MS analysis. Full scan 
parameters: Orbitrap resolution: 70,000; target value: 3,000,000 ions; maximum injection time of 20 
ms. MS/MS spectra parameters: Orbitrap resolution: 17,500; target value 1,000,000 ions; maximum 
ion collection time: 60 ms.  
The resulting raw files were analysed as above but with a later version of the Uniprot mouse data base 
(2014-10) and with deamidation of asparagine and glutamine residues defined as variable 
modifications.  
2.2.5 AHA pulse-chase of mouse fibroblasts 
Fully triple SILAC (Light:  Lys0, Arg0; Medium: Lys4, Arg6; Heavy: Lys8, Arg10) labeled mouse fibroblast 
where grown to ~25 % cell density. For the first two replicates two 10 cm plates were used per time 
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point and for the third replicate two 15 cm plates were used. Cells were starved for methionine as 
described above and then labeled with 1 mM AHA both for 1 h. After the pulse, Medium and Light 
cells were washed in PBS followed by SILAC DMEM before being chased in the same medium. The 
Heavy cells were instead washed in ice cold PBS before being scraped and spun down. Finally, the cell 
pellet was frozen. After the chase the Medium and Light cells were also scraped and frozen. The pellets 
were lysed as described for the “enrichment efficacy experiment”. In addition, click reaction, washing 
of beads, denaturation, alkylation and digestion were performed in the same way.  
In two out of the three experiments peptides were separated using strong anion exchange (SAX). The 
SAX protocol was performed as in (Wisniewski et al., 2009). In short, SAX material (3M) was put in 200 
µL pipette tips and activated by methanol. The SAX tip was then washed with high pH buffer (20 mM 
Acetic acid, 20 mM phosphoric acid, 20mM boric acid, pH was adjusted to 11 by titrating with 1M 
sodium hydroxide) before peptides were loaded onto the tip. The peptides were then eluted stepwise 
by decreasing the pH of the buffer in discrete steps (pH of 11 (flow though), 8, 5 and 3 all prepares as 
above with the addition of 0.25 M NaCl to the pH 3 buffer). In one experiment the peptides were pre-
fractionated by IEF into 12 fractions as described above. In all cases, the eluted peptides were stored 
on stageTips.  
IEF and SAX fractionated peptides were separated on a HPLC system as described above by either 4 or 
2 h gradients with a 250 nl/min flow rate on a 15 cm column packed in house with C18 material. 
Peptides were ionized using an ESI source and analysed on a Q-Exactive with the settings described 
above. 
The acquired raw files were analysed using MaxQuant as for the “enrichment efficacy experiment”. 
For all downstream analysis we used non-normalized SILAC ratios (see below for normalization 
procedure) with a minimum of 2 SILAC counts. Reverse database hits, potential contaminants and 
proteins only identified by site were all excluded.  
2.2.5.1 AHA pulse-chase data processing 
Note to reader: The normalization strategy was developed in collaboration with Celine Sin and Angelo 
Valleriani (MPI for colloids and interfaces). In addition, the AIC probability and parameter fitting where 
fully developed and implemented by Celine Sin and Angelo Valleriani. The protein feature analysis was 
developed by Henrik Zauber (MDC). Large portions of the relevant segments below are re-worked 
versions of their original texts.   
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2.2.5.2 Normalization 
Normalization is a challenge for experiments measuring abundances. Differences in starting material, 
labeling efficiency, etc. are all contributors to aberrations in measurements. A common normalization 
strategy is median-normalization, where the assumption is that the median values should not change 
throughout a series of experiments. However, for pulse-chase experiments, we expect the median to 
decrease over time, thus this strategy cannot be used. Instead, our normalization scheme is based on 
the assumption that there are stable proteins whose amounts decrease little during the time course 
of the experiment (Figure 18) (Schwanhäusser et al., 2011; Toyama et al., 2013). These proteins would 
remain unchanged and equal to 100 % remaining throughout the experiment. We can identify these 
very stable proteins because the Medium/Heavy and Light/Heavy SILAC ratios of these proteins should 
be among the highest in all experiments. Using this method, we identify the most stable proteins, and 
then calculate the multiplication factor necessary to normalize the data for each time point such that 
the geometric mean of the measurements of these very stable proteins will have a signal of 100 %. 
To find the most stable proteins, we consider proteins with data at all time points in all replicates to 
ensure that all normalization candidates are able to contribute to the normalization factor. For each 









ii t  
where the index i denotes the protein and PercentileRanki(t) maps the rank of each protein’s L/H or 
M/H signal strength (from smallest to largest, at time t) to the interval (0, 1).  Proteins with higher 
SILAC ratios at each time point will have higher scores. Thus, a protein who has the highest signal at 
all time points would have a score equal to the number of time points, which we call maxScore (i.e. 
the range of scores is [0, maxScore]). Each protein has up to 3 scores, one from each biological 









Candidates for normalization are those proteins with the lowest difference from the maxScore. From 
the data, we find the population of proteins with the lowest score deviations (LSD, n = 200, <5 % of 
total population) and deem these to be the stable proteins.  
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2.2.5.3 Parameter fitting 
In this study, we consider two simple models: a one-state model (exponential decay) and a two-state 
model (non-exponential decay).  In the 1-state model, proteins are born into state A (see Figure 20).  
From state A, they are degraded at the rate kA. The system is memoryless, meaning that the life 
expectancy for any single protein molecule does not change as the molecules age.  In other words, the 
1-state model models exponential decay. In the 2-state model, proteins are born into state A.  From 
state A, the molecule can immediately degrade at the rate of kA, or it can transition to state B with the 
rate kA-B.  Molecules that reach state B are degraded with rate kB. I.e. the life expectancy of the 
molecule depends on the age of the molecule, since the older a molecule is the more likely it is that it 
has transferred to the second state.   
In pulse-chase experiments, the duration of the pulse affects the composition of molecule ages at the 
beginning of the chase. For a very short pulse, the molecules synthesized in the pulse are likely to have 
the same age. However, for a longer pulse, molecules synthesized at the beginning of the pulse are 
“older” and might even be degraded while some molecules are just newly synthesized. Therefore, the 
length of the pulse must be taken into account for the calculations. 
The derivation of the mathematical description consists of two steps. The first is to translate the single 
molecule dynamics model into degradation from steady state at the level of population averages. The 
translation of single molecule dynamics to population averages has been covered in (Deneke et al., 
2013).  The second step takes the pulse into account and returns the degradation curve of the 
population averages. Calculation of the response of the system resulting from a pulse has been 
covered in (Sin, 2016).   
In our formalism, the function  t  defines the theoretical decay pattern, namely the fraction of 
molecules left after a decay of t time units. This function is expressed in terms of parameters defined 
through the underlying degradation model.  In our degradation model, we have assumed that the 
proteins follow either a 1-state model, in which there is only one degradation parameter, or a 2-state 
model, where there are three parameters.  The equations used for fitting are as follows: 
  tkAet      for the 1-state model 
      pp tGGt   for the 2-state model 






 20  
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Parameter estimation is performed by MATLAB through nonlinear fitting by minimizing the square 
deviation from the logarithm of the experimental data and the logarithm of the theoretical function.  
The routine employed for the nonlinear fit is fmincon. 
2.2.5.4 Model selection by the Akaike information criterion  
The Akaike Information Criterion indicates the quality of the model for a given set of data (Akaike, 
1974; Burnham K.P., 2002). Based on information theory, the AIC aims to find the model with minimal 
Kullback-Leibler distance between the proposed model and the “true” model (as assessed from the 
data). Models with more parameters have more degrees of freedom during the parameter estimation 
process, and can often deliver a more accurate fit to the data.  However, there is the danger of over-
fitting – that is the model could be approximating not only the system’s dynamics, but also quantities 
not related to the degradation, such as measurement noise. To decide which model we should adapt 
for each protein, we calculate the AIC for each model. The model resulting in the lowest AIC is the 
preferred model. We use the AIC with correction for small sample sizes to evaluate each of the two 



















where n is the number of data points, k is the number of parameters, and RSS is the residual sum of 
squares.  The AIC penalizes models with more parameters, worse fits, and less data.  That is, the AIC 
quantifies the trade-off between fit accuracy and model complexity. 
Furthermore, we can calculate the probability that a particular model i is the preferred one (relative 





























2.2.5.5 Delta-score (Δ-score) calculations 
If a protein is exponentially degraded, one can draw a straight line in a semi log plot between time 
point 0 h (100 % protein remaining) and the measured value for another time point and derive the 
relative protein abundance at any other time point. However, if a measurement for another time point 
is not on the line, allowing for measurement and quantification errors, the protein is non-
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exponentially degraded. We used this fact to estimate the size and direction (increased or decreased 
stability with age of the molecule) of the non-exponentiality of degraded proteins. We used the 
median % protein remaining at time point 8 h (tp8) after chase to calculate the expected relative 
protein abundance at time point 4 h assuming exponential degradation. For this we solved the straight 
line equation (y = mx + c) for x = 4h, where the intercept c is log(100%), and the slope m is calculated 




∗ 4h + log⁡(100%) 
Finally, we calculated the distance from the measured value, log(tp4), to the expected value, y(4h): 
𝛥 − 𝑠𝑐𝑜𝑟𝑒 = ⁡𝑦(4ℎ) − log⁡(𝑡𝑝4) 
This calculation was repeated for all proteins. The time points 4 and 8 h were selected because of the 
observation that most of the initial degradation of NED proteins had taken place by 4 h chase. Thereby 
we expected to be able to catch age-dependent stabilization (or destabilization) by comparing these 
two time points. Also, very few proteins had a half-life shorter than 2.5 h and could thereby not be 
detected at the 8 h time point (See supplemental table 1). In addition, these were almost exclusively 
exponentially degraded according to the AICp. 
2.2.6 Bioinformatic analysis 
Note to reader: The protein feature and complex centric analyses were developed by Henrik Zauber 
(MDC). Protein complex assembly and interface analysis was developed and performed by Jonathan 
N Wells and Joseph A Marsh (both at the University of Edinburgh). Their original texts have been 
slightly modified for this purpose.   
2.2.6.1 Degradation profile prediction from different protein features 
The following features were selected to test each for prediction power of protein degradation profiles. 
The “Part of a Complex” feature distinguished proteins listed and not listed as a member of a protein 
complex as defined in (Ori et al., 2016). Protein Length refers to the protein sequence length and was 
taken from the Uniprot FASTA table (version 10.2011). “Protein abundances in steady state” refer to 
average protein copy numbers per cell (Schwannhäuser et al. 2011) mapped by Uniprot accessions 
and gene names if the Uniprot accession was not mapped. Disordered, Helix and Beta Sheet fractions 
per protein were taken from secondary structure predictions using the s2d method (Sormanni et al., 
2015). The feature “Low Complexity Region” were obtained from the “mmusculus_gene_ensembl” 
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dataset from the biomart database (status 14.10.2015). Listed lengths of Low Complexity regions were 
summed up per protein. Features related to structure were length-normalized. For each feature a 
ROC-curve was generated and the area under the curve (AUC) calculated using the pracma R-package. 
The robustness of the calculated AUCs was tested by running 200 bootstrap repetitions. The 90 % 
confidence intervals of the resulting AUCs are shown as error bars in the corresponding bar plot. Each 
feature was additionally randomized, resulting in a real AUC and a random AUC population. Each 
feature prediction was tested for being absent or present by reversing the sorting vector. In each case 
the positive AUC was reported and labeled with “absence” or “presence” of the corresponding 
feature. 
2.2.6.2 N- and C-terminal protein abundance analysis   
In silico division of all proteins in the mouse data base, re-matching of all identified peptides and 
plotting was done using R. Only peptides that were matching uniquely to the protein N- or C-terminus 
were retained.  
2.2.6.3 Estimation of relative protein abundance after pulse  
To estimate the protein abundance after the pulse we used intensity based absolute quantification 
(iBAQ, (Schwanhäusser et al., 2011)). First we calculated iBAQ values for proteins based on the H-
intensities (derived from the newly synthesized proteins without chase). Second, we normalized these 
iBAQ data from the three experiments using the median H-intensities for the LSD-proteins (see 
normalization above). This allowed the combination of experiments. Finally, we reported the median 
protein H-iBAQ from the three experiments as the protein abundance.  
For a complex-centred analysis of the relative protein abundances after pulse, identified proteins from 
the mouse dataset were mapped to a filtered version of PDB (see supplemental table 3) using gene 
names. Protein abundances were normalized in a complex centred manner: First all proteins that 
mapped to a complex were extracted. Second, stoichiometric differences between subunits within a 
complex were normalized out by dividing each protein abundance against the listed stoichiometry in 
the PDB database. Third, abundances of all proteins of a complex were normalized to the average 
abundance of each complex. The resulting complex-centred abundances were compared between the 
protein subsets ED, NED and UN. Only proteins from complexes with at least one ED and one NED 
subunit were considered for the analysis.  
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2.2.6.4 Protein complex assembly and interface analysis 
All protein structures in the Protein Data Bank (2016-02-24) were searched for polypeptide chains 
with more than 70 % sequence identity to a mouse or human gene. If multiple matches were detected, 
a single chain was selected by sorting by sequence identity, followed by number of unique subunits in 
the complex, and finally the number of atoms present in the chain. AREAIMOL was used to calculate 
pairwise interfaces between all pairs of subunits (Winn et al., 2011). For all complexes, excluding those 
containing nucleic acid chains, the normalized assembly order was calculated by first predicting the 
(dis)assembly pathway using all the pairwise interfaces from each heteromeric complex using 
the assembly-prediction package (Marsh et al., 2013; Wells et al., 2016). For subunits represented by 
multiple copies within a single complex, the mean assembly order of each subunit type was 
considered. The normalized assembly order was calculated so that the last subunit to assemble has a 
value of 1, the first has a value of 0, and the average value for all unique subunits in a complex is equal 
to 0.5. 
2.2.7 Serial dilution experiment 
Heavy and Light-labeled NIH 3T3 mouse fibroblasts were lysed in RIPA buffer as above. Protein 
concentrations were measured by Bradford assay using the “Coomassie Plus” kit (Pierce). Heavy 
proteins were serial diluted into the Light protein solution. The mixed proteins were then precipitated, 
denatured, alkylated, digested and stageTipped as described above. Each dilution step was analysed 
using a 2 h gradient of increasing Buffer B concentration on a 15 cm column and measured on a Q-
Exactive as described above. The resulting raw files were analysed as for the “enrichment efficiency 
experiments” but this time once with “reQuantify” once active and once inactive.  
2.2.8 SILAC pulse-chase (confirmation experiment)  
Mouse fibroblasts were grown to 80 % confluency in 15 cm plates in Light SILAC DMEM. Cells were 
washed three times in PBS before being pulsed in Heavy SILAC DMEM for 4 h (or as annotated in Figure 
48). Cells were then washed in PBS before being trypsinated for 2 min at 37 °C. Detached cells were 
diluted in PBS before half of the cells were transferred to a 10 cm plate containing Medium SILAC 
DMEM and the other half spun down and the pellet then frozen. After the Medium chase (see Figure 
48 for different chase times), cells were also spun down and frozen. Additional “label-swap” 
experiments were performed in the same fashion. However, in the label-swap experiments the cells 
were pulsed with Medium and chased in Heavy amino acids (see Figure 48). Cell pellets were lysed 
and proteins denatured in 0.2 % SDS, 0.1M DTT and 50 mM ABC buffer (pH8) by boiling for 10 min at 
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95 °C. After cooling, Benzonase was added for 10 min before cell lysates were spun down and 
supernatants were transferred to fresh tubes. Proteins were alkylated by adding iodoacetamide to a 
0.25 M final concentration, in the dark, for 20 minutes. Proteins were precipitated by Wessel-Flügge 
precipitation, digested “on bead” and stageTipped as in the “dynamic SILAC experiment”. The peptides 
were resolved on a 4 m long monolithic column using a 12h gradient of increasing buffer B 
concentration and a flow rate of 500 nl/min. Peptides were ionized by ESI and analysed on a Q-Exactive 
Orbitrap. Resulting raw files were analysed on MaxQuant with the same parameter settings as for the 
AHA p-c experiment. Plotting and statistics were performed using R and figures were modified in 
Illustrator. 
2.2.9 Inhibitor experiments  
Inhibitor treatment experiments were performed as the AHA p-c experiments but only with three time 
points (0, 4 and 8h). In addition to pulsing the cells with 1 mM AHA different inhibitors or vector 
control dimethyl sulfoxide (DMSO, Biomol) were added. rRNA synthesis was blocked by the addition 
of 100 nM Actinomycin D (Sigma-Aldrich) during the both the pulse and chase. Proteasomes were 
blocked using 20 µM MG132 (Cayman chemical) and autophagy was blocked by a combination of 250 
nM Bafilomycin A1 (Invivogen) and 500 nM wortmannin (Calbiochem) both treatments were added 
only during the chase.  
Inhibition of autophagy was monitored by taking a sample for western blotting. Scraped cells were 
directly lyzed in LDS sample buffer (NuPAGE, Invitrogen) supplemented with DTT. Samples were run 
on 4-12 % gradient Bis-Tris gel (NuPAGE, Invitrogen) before being blotted onto a PVDF membrane 
(Immobilon-P, Millipore) using a wet blotting contraption. The membrane was probed against LC3-II 
(Novus NB100-2220) and was afterwards stripped at 37 °C for 15 min in 2 % SDS and 2 % β-
mercaptoethanol in 65 mM Tris Base (pH6.7, Roth) before being re-blotted with an antibody specific 
for β-actin (Sigma-Aldrich A5441). 
Cells for mass spectrometric analysis were scraped, lysed, and had their AHA labeled proteins clicked 
to alkyne-agarose beads. Proteins were reduced and alkylated before beads were washed. Proteins 
were digested “on bead” by LysC and then trypsinated overnight all as in the main AHA p-c experiment. 
Peptide solutions were put on 4mm/1ml C18 columns (Empore, 3M) and washed in buffer A. Peptides 
were eluted in buffer B and vacuum dried.  
Peptides derived from MG132 samples were loaded on a column packed with 2:1 mixture of 3 µm 
weak anion exchange beads (WAX, PolyLC Inc.) and 3 µm strong cation exchange beads (SCX, PolyLC 
Inc.) followed by a C18 “trap” segment (Motoyama et al., 2007). The peptides were subsequently 
 




   31 | P a g e  
 
eluted with increasing salt concentration (ammonium acetate in 4, 8, 16, 32, 64 and 500 mM steps) 
onto the C18 trap part of the pre-column. Each fraction eluted from the WAX/SCX material where then 
separated on a 15 cm column with 2 h gradients of increasing buffer B concentration with a 250 nl/min 
flow rate. Autophagy inhibited samples were put on SCX tips and washed in no salt buffer, as described 
above, to minimize polymer contamination. Samples were then eluted with 500mM ammonium 
acetate before being desalted on stageTips. Eluted samples were separated using an 8 h gradient on 
a 2,000 mm monolithic column with a flow rate of 300nl/min. Actinomycin D samples were put on SCX 
tips but manually fractionated by eluting in steps by increasing ammonium acetate concentration in 
8, 16, 32 and 500 mM steps before being put back on stageTips (Kulak et al., 2014). Eluted samples 
were separated on a 15 cm column using 2 h gradients. 
Peptides were ionized using an ESI source and analysed on a Q-Exactive with the above described 
settings. ESI and mass spectrometer setting were, for all samples, as described above. The resulting 
raw files were analysed using MaxQuant as the standard AHA p-c experiment.  
Protein profiles were normalized using values from LSD proteins branded in the AHA p-c mouse 
dataset. From this normalized dataset Δ-Scores were calculated for each, treatment and control, as 
described above. The difference of the Δ-Scores between treatment and DMSO control was compared 
for the two protein subsets identified as NED, ED and UN.  
2.3 Experiments using human RPE-1 and RPE-1 trisomic cells 
Note to reader:  Chromosome spreads were performed by Neysan Donnelly and Zuzana Storchova 
(MPI of Biochemistry) and whole genome sequencing and data analysis was performed by Xi Wang, 
Jingyi Hou and Wei Chen (all MDC). Some of the segments below are modified from their original 
versions.   
2.3.1 Preparation of chromosome spreads and chromosome painting  
Cells were grown to 70-80 % confluency before treatment with 50 ng/ml colchicine for 3-5 hours. 
Subsequently, cells were trypsinated and centrifuged at 250 rcf for 10 min. Pellets were then 
resuspended in 75mM KCl and incubated for 10-15 min at 37 °C. After centrifugation at 150 rcf for 10 
min, cell pellets were resuspended in 3:1 methanol/acetic acid for fixation. Finally, cell pellets were 
washed several times in 3:1 methanol/acetic acid, spread on a wet glass slide and air-dried at 42 °C 
for 5 min. Each sample was labeled with probes for two different chromosomes. Probes (Chrombios 
GmbH, Raubling, Germany) for chromosome 5, 11 and 12 were tagged with FITC and TAMRA, 
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respectively. The chromosomes were labeled according to the manufacturer's instructions and 
counterstained with DAPI. Images were obtained by a fully automated Zeiss inverted microscope. 
2.3.2 Genomic DNA sequencing and copy number estimation 
DNA was isolated using the Blood and Cell Culture DNA kit (Qiagen) according to the manufacturer’s 
recommendations. 1 g genomic DNA was sheared following the protocol from the SureSelect Target 
Enrichment System Kit for Illumina Multiplexed Sequencing (Agilent Technologies). Genomic DNA 
sequencing library was prepared with 100 ng sheared genomic DNA using TruSeq ChIP Library Prep Kit 
according to the manufacturer’s guidance (Illumina). The libraries were sequenced in 1 x 100 nt 
manner on HiSeq 2000 platform with a depth of ~30 million reads per library (Illumina). Sequencing 
reads were aligned to the human reference genome (hg19) using Bowtie (version 2.1.0) with default 
parameters, and only uniquely mapped reads were kept for downstream analysis. With a sliding 
window of size 100 Kb and a step size of 50 Kb, mapped reads in each window were then counted and 
used for copy number estimation. With the assumption that most genomic regions for the cells were 
diploid, we took 𝐶𝑖 given by the following formula as the copy number estimates for genomic location 
at the ith window:  






where 𝑅𝑖 is the read counts of the ith window. To avoid underestimating copy numbers for regions 
with multi-aligned reads, we adjusted for mappability based on mapping of simulated reads with 
uniform coverage across the genome. The original read counts were divided by the read counts in the 
same window obtained from the simulation data, and the adjusted read counts were instead used for 
copy number estimation.  
2.3.3 AHA p-c of RPE-1 and RPE-1 trisomic cells  
RPE-1 and RPE-1 trisomic cells were grown, methionine-starved, AHA-pulsed, chased and lysed as 
described for the mouse fibroblast. 3 biological replicates were performed per cell line. Experiments 
were started when cells reach ~30 % confluency to avoid that the cells reached full confluency during 
the 32 h of chase. Two 15 cm plates were used per time point. Click chemistry, denaturation, 
alkylation, washing and digestion were performed as described for the mouse cells. Peptides were 
stageTipped on 4 mm/1 ml C18 columns (3M). Eluted samples were speedVacced and for two of the 
samples Buffer A was added to 10 µl final volume. Of these, 5 µl was loaded onto a 15 cm column and 
5µl onto a 2m monolithic column using a HPLC system. The samples were analysed on a Q-Exactive 
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orbitrap system, as described above, employing 4 and 6 h linear gradients of increasing Buffer B, for 
the 15 cm and 2 m column respectively. For one sample the peptides were further SCX fractionated 
into 2 fractions by 125 mM and 500 mM ammonium acetate as described above. These samples were 
analysed using 4 h gradients of increasing Buffer B concentration over a 15 cm column. The resulting 
raw files were analysed using MaxQuant with previously described parameters, with the exception 
that the Andromeda search engine was matching to the Human Uniprot database (2014-10). 
Normalization, fitting of models, Δ-score and abundance after pulse calculations were performed as 
for the mouse fibroblasts.  
2.3.4 Steady state protein abundance  
Fully Heavy SILAC labeled RPE-1 and Light labeled RPE-1 trisomic cells were grown in 10 cm plates to 
70 % confluency. Cells were scraped in ice cold PBS before being spun down at 1000 rcf and PBS 
decanted. Cell pellets were lysed in 1.3 % SDS, 0.1 M DTT in 50 mM ammonium bicarbonate solution. 
Samples were heated to 95 °C for 10 min. After cooling the samples, Benzonase was added for another 
10 min. The samples from the two cell lines were then mixed 1:1 and spun down at 20,000 rcf to clear 
cell debris. Proteins in supernatant were alkylated by the addition of 0.25 M iodoacetamide, final 
concentration, and left in the dark at room temperature for 20 min. After alkylation samples were 
directly Wessel-Flügge precipitated, resuspended in Urea buffer, “on bead” digested and stageTipped 
all as described above. Eluted peptides were analysed using a 6 h gradient on a 15 cm column as 
described above. The Q-Exactive was run with standard settings and raw files were analysed as 
described for the “AHA p-c experiment”. MaxQuant output was filtered as described above but this 
time normalized SILAC ratios were used for downstream analysis. A label swap experiment was also 
performed where RPE-1 cells were grown in Light SILAC medium and RPE-1 trisomic cells were grown 
in Heavy SILAC medium. 
2.3.5 Bioinformatics of RPE-1 cells 
Delta-score (Δ-Scores) and abundances after pulse were calculated for the datasets of the RPE-1 and 
the RPE-1-trisomic cell line as described in the previous sections. For the conservation analysis, 
proteins identified in RPE-1 were mapped to proteins from the mouse data using the first entry in the 
gene name column from the proteinGroups.txt tables. Mapped proteins from mouse that fell into the 
categories ED, UN and NED were compared to the fraction of mapped proteins identified in RPE-1.  
RPE-1 and RPE-1 trisomic datasets were merged using the leading protein ID in each protein-group. 
Proteins were linked to chromosome positions using the human reference genome (hg19). Proteins 
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were first mapped to chromosome positions based on Uniprot IDs. Remaining unmapped proteins 
were mapped using gene name entries as provided in the Uniprot FASTA file. Overall, 2529 proteins 
had comparable quantitative information between the RPE-1 and RPE-1 trisomic cells. Proteins were 
further grouped into the categories disomic, trisomic or ambiguous. Disomic proteins included all 
proteins that mapped to disomic chromosomes as identified by genome sequencing. Trisomic regions 
included proteins mapping to chromosome 5 and chromosome 11 downstream from position 
62650000. Chromosome 12 and 10 starting from nucleotide position 62500000 were considered to be 
ambiguous since they show partial aneuploidy already in the RPE-1 cell line. Only autosomes were 
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3 Results 
3.1 Establishment of azidohomoalanine labeling 
To study protein degradation kinetics we employed a combination of fully SILAC labeled cells with 
pulse-chase by the non-natural amino acid azidohomoalanine (AHA) (Figure 9). AHA is metabolically 
incorporated into newly synthesized proteins in place of methionine (Kiick et al., 2002). In contrast to 
methionine, AHA contains an azido group which makes it suitable for click chemistry. In principle, any 
functionality containing an alkyne, e.g. biotin or fluorophores, can be clicked to an AHA-containing 
protein (Dieterich et al., 2006; tom Dieck et al., 2015). In our approach, we combine AHA-labeled 
protein with alkyne-bearing agarose beads. By selectively labeling newly synthesized proteins with 
AHA, one can then efficiently enrich this population and analyse it by mass spectrometry (Dieterich et 
al., 2006; Eichelbaum and Krijgsveld, 2014; Eichelbaum et al., 2012).  
In the AHA pulse chase (AHA p-c) method presented here we label Light, Medium-heavy and Heavy 
SILAC cell cultures for 1 hour with AHA (Figure 10). These AHA-labeled newly synthesized proteins are 
the age-defined (0 - 60 minutes old) population that we follow during the chase. One of the cultures 
we directly collect (0 hour time point) while the other two we chase in medium depleted of AHA 
(“cold” chase) for different amounts of time. We then combine the samples with different SILAC labels 
and enrich the newly synthesized proteins. Finally we measure the samples using shotgun proteomics. 
The SILAC labels allow us to quantify how much of the proteins are left after the different chase times 
(Figure 10). By combining results from multiple experiments, we can cover many time points.  
When establishing AHA p-c, we were mainly concerned with the potential impact of the unnatural 
amino acids on the cells and the proteins that had incorporated AHA. In this segment I will discuss the 
influence of AHA labeling on two of the most important biological parameters, namely protein 
synthesis and degradation. I will also discuss the more technical factor which is the enrichment 
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Figure 9. Azidohomoalanine is a “clickable” amino acid.  
Upper panel compares the structural formula of azidohomoalanine (AHA) to methionine. AHA is 
metabolically incorporated into newly synthesized proteins instead of methionine (Kiick et al., 2002). 
Lower panel displays the principle of the chemical “click” reaction (Eichelbaum et al., 2012). Copper-
catalysed 1,3-cycloaddition covalently couples the AHA-containing new proteins to alkyne-bearing 
agarose beads. The highly stable triazol-group allows for stringent washing of the beads without loss 
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Figure 10. Azidohomoalanine pulse-chase (AHA p-c) experiments.  
Fully SILAC labeled methionine starved cells are pulsed with AHA for 1 hour. The Heavy SILAC cells are 
then directly collected whilst the Medium and Light SILAC cells are chased in medium depleted of AHA 
but containing methionine (cold chase). After different amounts of chase time, during which the AHA-
containing proteins can only degrade, the cells are collected and lysed. The samples are then 
combined and alkyne-agarose beads and click chemistry are used to enrich the AHA-bearing proteins. 
The proteins are then digested “on bead” before being analysed by LC-MS/MS. Using the SILAC ratios, 
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3.1.1 Long AHA-pulses lead to decreased protein synthesis 
The first thing we wanted to understand was the impact of AHA-labeling on cells and proteins. One 
risk of using an artificial amino acid is that it will impact protein synthesis rates. To estimate protein 
synthesis levels when using AHA, I performed dynamic SILAC experiments in which I pulsed 
methionine-starved cells with 0.2 mM methionine as a control or different amounts of AHA for 4 h 
(Figure 11). In parallel with the treatment, I also added Heavy (H) isotope labeled arginine (Arg10) and 
lysine (Lys8). One can then measure the amount of new Heavy proteins that have been synthesized 
compared to the old Light (L) population. By comparing the H/L ratio of protein in the methionine-
treated control cells to the H/L ratio in the AHA-treated cells, one can estimate the relative amount of 
new proteins in the different conditions.  
The results clearly show a decrease in the amount of proteins synthesized with a median of 67 % and 
65 % protein synthesized in experiment 1 (Figure 11) and 2 (n = 168, not shown), respectively. 
Interestingly, protein synthesis did not increase when titrating with more AHA (Figure 11). This finding 
is consistent with the fact that the methionyl-tRNA synthase has a 400 fold higher catalytic efficiency 
when methionine is the substrate as compared to AHA, suggesting that 1 mM AHA already saturates 
this potentially rate limiting step (Kiick et al., 2002).  
Another interesting finding is that when AHA was added in combination with methionine, protein 
synthesis levels were rescued (Figure 11). This is consistent with previously published data (Bagert et 
al., 2014). In that study, Bagert and colleagues demonstrated that mixing AHA and methionine in a 
1:30 ratio limited the impact of AHA on protein synthesis, even though it also significantly decreased 
the amount of AHA-containing proteins. Importantly, that the combined AHA and methionine 
treatment rescues protein synthesis indicates that the addition of AHA per se is not toxic for the cell.  
A gene ontology analysis (not shown) of the data indicates that proteins involved in protein synthesis 
and in cell cycle progression are the least synthesized populations when methionine is exchanged for 
AHA (Huang et al., 2009). A look at only ribosomal proteins confirm this picture, with a median of 31 
% (Figure 11, right panel) and 35 % synthesis levels of these proteins in the first and second (n=6, not 
shown) experiment, respectively. A decrease in synthesis of these populations of proteins could 
indicate that the cell experiences amino acid starvation on top of the above discussed tRNA loading 
deficiencies (Efeyan et al., 2012). Methionine is used for many purposes in the cell, such as DNA 
methylation, and the cell senses and responds to the lack of this and other amino acids (Efeyan et al., 
2012). In summary, the addition of AHA does not seem to fully compensate for the methionine 











Figure 11. AHA labeling leads to decreased protein synthesis compared to methionine control.  
4 h of pulse labeling with different concentrations of AHA or 0.2 mM (standard concentration in 
DMEM) methionine in combination with Heavy lysine and arginine. A) H/L ratios of methionine treated 
cells were set as 100 % protein synthesis. Using the ratio of ratios, we estimated the fraction of protein 
synthesis during the titration of AHA. When using 1mM AHA, proteins were synthesized with a median 
67 % efficiency. Increasing the levels of AHA did not rescue synthesis rates. However, adding 
methionine to the AHA-treated cells rescued protein synthesis (magenta). n = 30, proteins that overlap 
in all 6 conditions (i.e. the same proteins are plotted for all densities). B) Looking specifically at the 
ribosomal proteins (purple, n=3), they were more decreased when using 1mM AHA than the average 
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3.1.2 AHA-labeled proteins can be efficiently enriched  
To establish how well we could enrich AHA-labeled proteins, I performed a classical radioactive pulse 
experiment. I labeled proteins with either methionine or AHA in combination with 35S cysteine for 1 h 
(Figure 12 A). I then lysed the cells and performed the click chemistry. Finally, I quantified the 35S 
derived radioactivity in the supernatant and on the beads. I found that I could pull down 70 % of the 
radioactivity when I labeled the proteins with AHA (Figure 12 B). In contrast, the vast majority of the 
radioactivity stayed in the supernatant in the methionine-treated cells. Due to recirculation of 
methionine and the fact that not all proteins contain methionine we would not expect that all proteins 
would be labeled by both AHA and cysteine, especially after such a short pulse. In conclusion, we can 
enrich AHA containing proteins with 70 % efficiency after a 1 h pulse. 
 
 
Figure 12. Enrichment efficiency of newly synthesized AHA-containing proteins by click chemistry 
using alkyne beads. A) Experimental setup: NIH 3T3 cells were labeled in parallel with 35S Cysteine and 
either methionine (Met) or azidohomoalanine (AHA). Scintillation counter measurements were taken 
of the supernatant after the click reaction and of AHA-bearing proteins covalently bound to the alkyne-
beads (beads). B) The scintillation counts from two experiments were normalized to the total signal 
(beads + supernatant) to enable direct comparison between the replicates. When AHA was used, the 
majority ~70 % of radioactively labeled proteins were attached to the beads in comparison to less than 
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3.1.3 Short AHA-pulses have minor effect on protein synthesis 
Because of the large population of pre-existing Light proteins in the dynamic SILAC experiments, I was 
limited to a relative long pulse of 4 hours to properly quantify the newly synthesized Heavy proteins. 
This pulse time was significantly longer than the 1 h we planned to use for the AHA p-c experiments. 
Therefore I additionally performed radioactive pulse experiments to determine the effect of shorter 
AHA-pulses on protein synthesis. I labeled methionine-starved mouse fibroblasts with 35S cysteine and 
either 1mM methionine or AHA for 1 h (see time point 0 h in Figure 14 A). I then quantified the 
incorporated radioactivity as a measure of protein synthesis. A trend towards less proteins synthesis 
(~90 % of control levels) in the AHA treated cells was visible, although not statistically significant. 







Figure 13. Short pulses with AHA have a minimal impact on protein synthesis. 
NIH 3T3 mouse fibroblasts were starved for methionine and cysteine for 45 min before being pulsed with 35S 
Cysteine in combination with either 1mM of Methionine or azidohomoalanine for 1 h. Proteins in cell lysates 
were resolved on a SDS-PAGE (see time point 0 h in Figure 14 B). Proteins were fixed in the gel and stained by 
Coomassie blue. Subsequently, the gel was dried before total loaded protein was estimated by the Coomassie 
blue stain and the radioactive signal was measured in a phosphorimager. Error bars: standard error, n = 6 
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3.1.4 AHA-incorporation has minimal impact on global protein stability 
Because the goal of this thesis is to look at protein degradation kinetics, the most important factor to 
consider is the potential effect of incorporating one or more AHA molecules on a protein’s stability. 
AHA has previously been shown to be non-toxic to sensitive cells, such as neurons, and to whole 
organisms, such as zebra fish and mice (Calve et al., 2016; Cohen et al., 2013; Dieterich et al., 2007; 
Hinz et al., 2012; McClatchy et al., 2015; tom Dieck et al., 2015). Nevertheless, there is a risk that AHA 
stabilizes or destabilizes proteins. To test this I performed radioactive pulse-chase experiments. They 
were performed by co-labeling proteins in mouse fibroblasts with 35S cysteine and either AHA or 
methionine (Figure 14 A). I either harvested pulse labeled cells directly or chased them for 6 or 24 h 
in “cold” medium depleted of radioactive amino acids but in the presence of either 10 fold cysteine 
and methionine or the protein synthesis inhibitor cycloheximide, which was added to prevent re-
incorporation of radiolabeled amino acids. When the three biological experiments from each chase 
conditions were quantified, I found no significant differences in the levels of newly synthesized 
proteins after 6 and 24 h of chase (Figure 14). This is consistent with similar studies on AHA and protein 
stability (Cohen et al., 2013; Howden et al., 2013; tom Dieck et al., 2015). In addition, previous groups 
have shown that AHA-containing proteins are not more ubiquitinated than normal proteins (Dieterich 
et al., 2006). AHA has even been used previously for pulse chase experiments (Chai et al., 2016; Cohen 
et al., 2013; Mirigian et al., 2014; tom Dieck et al., 2015). In conclusion, consistent with previous 
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Figure 14. AHA does not affect global protein degradation. 
A) Experimental design. Cells were co-labeled with 80µCi 35S Cysteine and either 1mM AHA or 1mM methionine 
(MET) for 1 h. The cells were then washed and chased in medium depleted of 35S cysteine but with 10 fold 
cysteine or cycloheximide added to prevent re-incorporation of radiolabeled amino acids. B) Radioactive 
proteins were probed on a dried SDS-PAGE gel. Figure shows one replicate from the cysteine chase experiment. 
C) and D) quantification of the cysteine chase (n=3 biological replicates) and cycloheximide chase (n=3) 
experiments, respectively. No significant differences in abundance after pulse were detected. Error bars: 
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3.2 Proteome-wide analysis of protein degradation kinetics 
After establishing that short pulses with AHA have a very limited impact on protein synthesis and 
degradation and that I can efficiently enrich the AHA-containing proteins, I set out to perform the AHA 
p-c experiments. In this segment I will discuss the AHA p-c method, including data normalization, cut-
off strategy, fitting of mathematical models and finally the categorization of non-exponentially 
degraded proteins. In addition, I will discuss some important controls, such as the estimation of the 
impact of background binding and SILAC ratio compression on the NED categorization. 
3.2.1 AHA pulse-chase experiments using mouse fibroblasts 
I set out to perform the AHA p-c experiments in NIH 3T3 mouse fibroblasts as outlined in Figure 10. I 
completed three experiments in which the Heavy cell population was always harvested immediately 
after the pulse and thus served as the common reference time point 0 h. I then chased proteins for 1 
and 2 h, 4 and 8 h and finally 16 and 32 h, respectively. Figure 15 A shows the data for three peptides 
belonging to the exponentially degraded proteins Filamin alpha (slow exponential kinetics) and 
Cathepsin L1 (fast exponential kinetics) and the NED protein Basigin (Tyler et al., 2012). As is apparent 
in Figure 15, Basigin levels rapidly decline until 2 h of chase after which they stay relatively stable over 
the 32 h of chase. We performed 3 biological replicates and in total identified 5247 proteins. The 
profiles for all the proteins are displayed in Figure 15 B and the three profiles from the examples in 
Figure 15 A are highlighted. More than 2000 proteins showed up in more than one biological replicate 
and could thus be used to assess reproducibility (Figure 16). Overall, the reproducibility was good with 
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Figure 15. AHA p-c of mouse fibroblasts. 
Upper panel shows example MS-spectra from the three experiments for three proteins. The three experiments 
were combined using the time point 0 h Heavy peaks (blue in plot) as a common reference point. Filamin alpha 
(Flna, represented by the peptide “ASGPGLNTTGVPASLPVEFTIDAK”) is relatively stable over the 32 h chase, while 
Cathepsin L1 (Ctsl1,”NLDHGVLLVGYGYEGTDSNK”) is rapidly degraded; both show exponential kinetics. Basigin 
(Bsg, “VLQEDTLPDLHTK”), a previously described NED protein, shows non-exponential kinetics also in AHA p-c. 
B) All the profiles from the 5247 quantified proteins in the three replicates (See Figure 16 A). The median values 
from the replicates were used for plotting. The three example profiles from A) are highlighted. For the 
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Figure 16. Overview of data processing and quality. 
A) Data filtering steps. 5247 proteins quantified with a FDR on both the protein and peptide level and 
using the 10 % cut-off rule (see below) were further filtered for the number of data points, residual 
sum of squares from the model fits (RSS, see below), measurements for Δ-scores (see below) resulting 
in 3292 protein profiles used for downstream analysis. B, E and H) Venn diagrams displaying the 
number of proteins overlapping in the three biological replicates after each filtering step. C, F and I) 
show the coefficient of variation (CV) after each filtering step for all overlapping proteins in B, E and 
H). The fraction of proteins in the shaded areas has a CV equal or smaller at each time point. D, G, J) 
The fraction of proteins covered by a fraction of data points at each time point. Figure generated by 
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3.2.2 AHA labeling does not induce detectable premature translational 
termination 
Unnatural amino acids could interfere with protein synthesis by interrupting the ribosome and 
inducing premature protein synthesis termination. Since we had measurements for thousands of 
newly synthesized proteins (the Heavy population, time point 0 h), I could now measure the 
occurrence of premature translational termination. If there were consistent ribosome fall-off, we 
would expect to find more peptides mapping to the beginning of the proteins. To investigate this 
possibility, I divided in silico all proteins in half and re-matched all identified peptides to either the N- 
or C-terminal end of the proteins. Peptides matching to the middle of the in silico divided proteins 
were discarded. We found no bias towards N-terminal peptides, indicating that no major ribosome 
fall-off was detectable (Figure 17). Furthermore, we found no difference in the distribution of the MS-
intensities, which roughly equals peptide abundance, between the N- and C-terminal peptides (Figure 
17). However, this does not fully exclude that premature translation termination takes place and that 
the resulting truncated proteins are degraded too fast for us to detect the difference between N- and 
C-terminal peptides. 
 
Figure 17. Distribution of intensities from newly synthesized Heavy peptides. 
The frequency distribution of Heavy peptides measured in the AHA p-c experiment is similar for N-
terminal (green line) and C-terminal (red) peptides. There is also no difference in the number of 
peptides that matched to the beginning (N-term, n=29055) or end (C-term, n=29287) of proteins. This 
suggest that AHA does not induce premature translational termination as this would skew the proteins 
mapping to the end of the protein to be less abundant, as judged by number of identifications and 
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3.2.3 Normalization of AHA p-c data 
Multiple errors can accumulate during the creation and handling of proteomic samples, e.g. 
differences in labeling efficacy, starting material, sample mixing and so forth. Therefore, most 
proteomic experiments require some form of normalization procedure. Mostly, the normalization 
strategy is based on an assumption that some proteins are always equally abundant in the cells (e.g. 
GAPH as a loading control in a western blot) or that most proteins are not affected by a treatment, for 
example, median normalization in a standard SILAC experiment. However, in the case of AHA p-c, none 
of these assumption can reasonably be expected to hold true. Instead, we based our normalization 
strategy on the assumption that the most stable proteins in our data are not degraded during the 
chase (Figure 18). We selected the 200 most stable proteins (least square deviation proteins, LSD 
proteins) based on their abundance at later time points during the chase (see Material and Methods). 
It is worth noting that results are relatively insensitive to the numbers of LSD proteins as long as they 
stay above 30 and below 200 (data not shown). In addition, since the whole population is shifted, the 
relative degradation profiles do not change much, even though the absolute values derived from the 
calculation, such as half-lives, do shift somewhat (data not shown). We then calculated the geometric 
mean for LSD-proteins to find the multiplicative factor that would shift the geometric mean to “100 % 
protein remaining” for this population. We then shifted the whole population accordingly. Each time 
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Figure 18. Normalization strategy. 
In A) the distribution of non-normalized data from one replicate is displayed. From the data in all 
replicates we identified the most stable (least square deviating, LSD) proteins (see material and 
methods). Example LSD proteins are highlighted in the grey arrow. The geometric mean for this 
population is showed in red in B). Note that all time points get an individual normalization value by 
shifting the time point specific geometric mean of the LSD proteins to 100 % remaining. C) The data 
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3.2.4 SILAC ratio compression and cut-off strategy 
A problem in SILAC-based strategies for quantification is ratio compression. Ratio compression is the 
underestimation of ratios that occurs when the true abundance ratios are very large. This could lead 
to false positive classification of NED proteins. For example, imagine that SILAC ratios larger than 1:5 
would always be reported at 1:5. Then proteins that were rapidly degraded would seem to stabilize at 
around 20 % protein remaining (i.e. a SILAC ratio of 1:5). The first thing I did to investigate this potential 
problem was to perform a serial dilution experiment (Figure 19). I diluted cell lysate from Heavy 
labeled mouse NIH 3T3 cells into Light cell lysate. I then performed the standard shotgun proteomics 
work flow (See material and methods). I analysed the resulting raw files twice using the MaxQuant 
software once with the reQuantify option active and once with reQuantify off. The reQuantify feature 
allows for detection of more extreme SILAC ratios that were not detected by the first round of analysis 
by the software (Cox et al., 2009). With reQuantify active, the SILAC ratios stabilized at ~1/7 and the 
number of quantified proteins stayed constant at around 1000. However, when reQuantify was 
deactivated the SILAC ratios stabilized at a much lower level ~1/31 (equivalent to 3 % protein 
remaining) and the number of quantified proteins dropped sharply. Consequently, we performed all 
analysis of the AHA p-c experiments with reQuantify turned off to minimize false positive stabilization 
of protein profiles (Cox et al., 2009). In addition, we applied a stringent cut-off to the AHA p-c data in 
which all data points below “10 % protein remaining” were change to NA (see also Figure 16). This 
further limits the effect of artificial stabilization of protein profiles by simply excluding the data in the 
potentially affected range (around 3 % protein remaining).  
In summary, ratio compression could have an impact on the AHA p-c data by “artificially stabilizing” 
degradation profiles of rapidly degraded proteins. We resolve this issue by excluding data points in 
the potentially affected range (< 10 % protein remaining) and by analysing the data in a conservative 
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Figure 19. Serial dilution experiment to assess ability to measure large SILAC ratios. 
 Heavy labeled SILAC NIH 3T3 cell lysate was serially diluted into Light SILAC labeled NIH 3T3 cell lysate. In total 
6 dilution steps were performed and analysed separately using LC-MS/MS. Raw files were analysed twice by the 
MaxQuant software, once with reQuantify parameter turned on (“ON” in figure) and once with reQuantify 
turned off (“OFF”). Upper panels show the H/L ratios when reQuantify is on or off. Red line indicates the 
expected values and black boxplots the distribution of measured values. With reQuantify on the ratios stabilize 
around 1/7, while when reQuantify is off the ratios reach ~1/31. The lower panels show the number of quantified 
(>1 SILAC count) proteins. It becomes clear that the number of quantified proteins drops rapidly when the ratios 
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3.3 Mathematic modeling reveals non-exponential degradation 
To systematically test if each individual profile represents a non-exponential or exponential case we 
employed Markov-chain based modelling approach. Celine Sin and Angelo Valleriani, both at the Max 
Planck Institute for Colloids and Interfaces, developed two mathematical models (Figure 20). In the 
first scenario, a protein is synthesized into a single state A (1-state model) from which they would be 
degraded with a certain degradation rate kA. This would model exponentially degraded proteins. In 
the alternative 2-state model, proteins are synthesized into the state A but can now either be 
degraded with rate kA or be transferred to a second state B with the transfer rate kAB. Importantly, the 
second state has a distinct degradation rate kB from the first state. This model would fit a non-
exponential scenario.  
All 5247 degradation profiles were fitted with each model and the number of data points-normalized 
residual sum of squares (RSS/n) was calculated (Figure 16). A probability for which model best explains 
the data was calculated using the Akaike information criterion (AICp, (Akaike, 1974)). In principle, the 
RSS/n was compared for both model fits and when they were similar the simplest model was selected 
to explain the data. This is because the fact that adding more parameters (the 1-state model has 1 
parameter whilst the 2-state models has three) will always result in an at least equal RSS/n (see 
examples in Figure 20). Therefore, the AIC is used to weight the 2-state model so that it is not used to 
explain data that could similarly well be explained by the simpler exponential fit. In other words, the 
AIC probability is a conservative approach to categorize NED profiles.    
We calculated AIC probabilities for all the profiles and retained proteins which had at least 5 data 
points (see Figure 16 and discussion below). The AIC only determines which of the tested models 
better explains the data with the least number of parameters. However, if none of the tested models 
explain the data well, the AIC would not be able to tell. We thereby excluded all profiles where the 
RSS/n was larger than 0.05 to exclude profiles that could not be explained well with either model 
(Figure 16). This resulted in 3605 proteins with an AIC probability (Figure 21 A). Out of these, 509 had 
a 2-state AICp higher than 0.8. We thereby conclude that a significant number of proteins are not 
exponentially degraded under our experimental conditions. 
We also reasoned that the degradation rates from state A and B could be used to determine if the 
proteins were becoming more or less stable over time. By simply comparing the first degradation rate, 
kA, with the second degradation rate, kB, we found that kA was always higher than kB. Thus, all 2-state 
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Figure 20. Markov chain modelling to distinguish between exponential and non-exponentially degraded 
proteins. 
Upper panel displays the two models used for determining exponential or non-exponential 
degradation. The 1-state model, in which a protein is synthesized into a state A and from where it can 
only be degraded, contains only one parameter. The 2-state model contains three parameters: two 
distinct degradation rates kA and kB and one transfer rate between the two states A and B (kAB). Note 
that the flow of the molecule is unidirectional and memoryless. The bottom panel shows the RSS/n 
for the two models when applied to the three example profiles from Figure 15. For Flna and Ctsl1 the 
two fits are almost identical and the AIC probability selects the simpler 1-state model. For Basigin the 
2-state model has a much better fit and consequently the AIC recommends the 2-state model. In 
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Figure 21. Distribution of AIC probabilities for the 2-state model. 
Histogram (left panel) displays the distribution of 2-state AIC probabilities (n = 3605). 509 proteins 
have a large probability (2-state AIC probability > 0.8). These proteins are exclusively stabilized by age 
as judged by their degradation rates in state A and B (right panel). In collaboration with Celine Sin and 
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3.3.1.1 Δ-scores quantify the size of NED 
The AIC probability only uses the RSS of the fits to determine which model better explains the data. It 
does not take into account the size of the non-exponentiality of degradation. To measure this we 
developed a simple score, the delta-score (Δ-score). The Δ-score is calculated using only the 0, 4 and 
8 h time points. We drew a straight line between the 0 h time point and the 8 h time point in a semi-
log plot (Figure 22 A). If the protein is exponentially degraded, we would expect that the 4 h time point 
measurement would land on the straight line. We thereby calculated the distance between the 
measurement and the straight line. This value is the Δ-score. A low Δ-score, a small distance between 
the straight line and the measurement, indicates that the protein is exponentially degraded. A large 
negative value would indicate that the protein is age-dependently destabilized and a large positive 
value that the protein would be age-dependently stabilized. 
 We selected the 4 and 8 h time points for the Δ-score calculations because the vast majority of the 
initial degradation was found to be completed before 4 hours of chase (e.g. see Basigin in Figure 15). 
In addition, very few protein were degraded so rapidly that they lacked data for the 8 h time point. 
Finally, these rapidly degraded proteins were almost exclusively exponentially degraded (See 
supplemental table 1). Therefore, by using the 4 and 8 hour time points we capture the NED of most 
proteins.    
3.3.1.2 NED categorization 
Employing the Δ-score and the AIC probability, we defined NED proteins as proteins that had a 2-state 
AICp higher than 0.8 and Δ-score larger than 0.15. This ensures that NED proteins not only have non-
exponential degradation profile but also that they are strongly non-exponentially degraded. 
Conversely, ED proteins were defined by having a 2-state AIC probability lower than 0.2 and an 
absolute Δ-score lower than 0.15. Proteins falling outside these definitions we simply refer to as 
undefined (UN) from here on. It’s worth noting that UN is a purely technical definition and most 
undefined profiles would probably be categorized either as ED or NED if more data would be gathered. 
In any case, the NED population becomes more robustly defined when taking into account both the 
probability and size of the effect. 
Using these definitions we found 331 proteins (10 %) that show strong NED while 1622 (49 %) display 
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Figure 22. 10 % of all proteins are strongly non-exponentially degraded (NED). 
A) Δ-scores are calculated by drawing a straight line between time point 0 h and 8 h. The distance from 
the measured 4 h time point and the straight line is then calculated. A large distance, or Δ-score, 
indicates non-exponential degradation since the definition of exponentiality is the fact that the 
measurements should fall on a straight line in a semi-log plot. B) Using the Δ-score and the 2-state AIC 
probability, we defined three categories of proteins NED, ED and undefined (UN). NED proteins have 
a probability for the 2-state model > 0.8 and a Δ-score > 0.15. ED proteins, in contrast, are defined by 
having a 2-state AIC p < 0.2 and an absolute Δ-score < 0.15. The remaining proteins are considered 
undefined. This should be considered a technical definition and probably does not reflect biology. 
Collection of more data points would most likely lead to the proteins within this category to be defined 
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3.3.1.3 Number of data points required 
Another question that arose was the number of data points that are required to make a distinction 
between the two models. To investigate this we used a bootstrapping approach. We took the data 
from two profiles, one of an ED and one of a NED protein (Figure 23). We then randomly sampled a 
number of the data points from each profile. We performed 500 replicates for each number of data 
points selected, i.e. the boot strappings were performed by grabbing 4 random measurements from 
the Uba2 profile 500 times and then grabbing 5 time points another 500 times and so forth. We found 
that when using 5 data points we recalled the vast majority of Basigin profiles as either undefined or 
NED. By using seven data points we were almost 100 % correct. The ED protein was much less sensitive 
to the number of data points. This finding reflects the conservative approach we took when identifying 
NED proteins. In summary, a NED protein with 5 data points measured will be correctly classified many 
more times than it would be incorrectly recalled as an ED protein. We therefore used profiles with a 
minimum of five data points for the NED categorization (see also Figure 16). 
 
 
Figure 23. Impact of the number of data points on our classification.  
We used the experimental data for a NED protein (Basigin, left) and an ED protein (Uba2, right). From 
these data, we generated sub-samples of different sizes (that is, “Data Points”) using bootstrapping 
(500 profiles per sample size). We then applied our AIC-based modelling, computed Δ-scores and 
applied our cut-offs. The number of profiles that were classified as NED, ED and UN is shown as a 
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3.4 Background binding has a minimal impact on NED categorization 
3.4.1.1 Measurement of background binding  
A potential technical issue could be unspecific binding of proteins to the alkyne-beads. If proteins 
would display high background binding, this would once again introduce false positive NED profiles by 
artificially stabilizing rapidly degrading proteins. Imagine a protein that has very high background 
binding levels. In this case we might not be able to detect degradation at all since the large population 
of old proteins would mask the signal from the enriched AHA-labeled newly synthesized proteins.  
To estimate the amount of background binding I performed a control experiment in which I AHA-
labeled a population of fully Heavy SILAC labeled cells (Figure 24). I then mixed these cells 1:1 with 
unlabeled Light cells. I enriched the AHA containing proteins and performed shot gun proteomics. If 
the enrichment was specific, we would expect to only find Heavy peptides. In contrast, background 
binders should show up in the light channel. I detected 4673 proteins in the first replicate. Out of 
these, 3034 were detected only in the Heavy channel (infinity ratios). 47 showed up only in the Light 
channel and contained mainly proteins, such as serum albumin, that have an extracellular origin and 
proteins with very few identified peptides, both groups probably representing contaminants. 1556 
proteins showed up in both channels with a median ratio larger than 11. Therefore, the vast majority 
of protein are below the conservative 10 % cut-off, limiting the potential impact of background binding 
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Figure 24. Enrichment specificity of AHA bearing proteins. 
The experimental design is shown in A). Fully Heavy SILAC labeled NIH 3T3 cells were pulsed for 2.5 h 
with AHA. After the pulse the cells were mixed 1:1 with fully Light labeled cells which had not been in 
contact with AHA. The standard click-reaction and enrichment procedure was performed and the 
resulting peptides were analysed by LC-MS/MS. By measuring the H/L ratio we can estimate how much 
of the signal comes from proteins that potentially can contain AHA (Heavy channel) compared to 
background binders or other contaminants (Light channel). The results from one such experiment are 
displayed in B). As expected, most proteins (n = 3034) show up only in the Heavy channel. Very few 
protein (n = 47) show up only in the Light channel. 1556 more abundant proteins, as judged by their 
high summed intensity, show up in both channels. C) The potential background binding population 
was found to be highly reproducible with many of the same proteins showing up with a similar ratio 
in all three experiments analysed. The median ratio for the three experiments was > 11. Analysis in 
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3.4.1.2 Subtraction of background signal has limited impact on NED categorization 
Since we had defined the NED, ED and UN populations, we decided to further test the impact of 
potential background binding on our categorization. Even though the majority of proteins did not 
show any background binding in the assay (Figure 24), the proteins that did display background 
binding showed highly reproducible values (Figure 24 C). For the group of proteins that showed 
background binding, we used the data from Figure 24 and calculated a protein-specific background 
binding value (i.e. the % of signal that was potentially derived from background binding). We then 
simply subtracted this value from the AHA p-c experiment and rescaled the values. With this new data, 
we re-performed all the AICp and Δ-score calculations. Finally, we compared these results with the 
previous results using the 10 % cut-off (Figure 25). We found that very few proteins were affected by 
the protein-specific background subtraction and therefore decided to use the simpler 10 % cut-off 
strategy.  
 
Figure 25. Impact of different strategies to deal with background binding.  
The plots show the Δ-scores (left) and AIC probability (right) using either the 10 % cut-off strategy (x-
axes) or subtraction of the protein-specific background (y-axes). Protein-specific backgrounds were 
derived from the enrichment experiment shown in Figure 24 and subtracted from the experimental 
data. If no ratio was measured in Figure 24, the standard 10 % cut-off was applied also to these 
proteins. With the new values, the standard modeling and Δ-score calculations were performed. Plot 
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3.5 Confirmation of NED categorization 
When we had defined NED and ED proteins by AHA p-c, we sought to confirm our definitions with 
alternative methods. I will discuss in this segment the orthogonal methods we used to confirm our 
categorization and the results gained. 
3.5.1 AHA p-c provides half-lives similar to previously published  
A good starting point when confirming one’s findings is to check that the data matches published 
literature. The first thing we did was to see if the half-lives we had calculated correlate with a 
previously published data set using the same cell line (Schwanhäusser et al., 2011). The previously 
published half-lives were quantified using a dynamic SILAC approach which is very different from the 
AHA p-c approach. We first compared the half-lives from the exponentially degraded proteins to 
Schwanhäusser et al. and found a good correlation (r = 0.645, Figure 26). It was also comforting to see 
that the absolute values of the half-lives reported were similar. It should be noted that half-lives larger 
than 300 h were excluded since we cannot accurately quantify them in our approach with the longest 
chase time being 32 hours.  
For the NED proteins we applied two different approaches. First, we compared the exponential half-
lives from the 1-state model fit (Figure 26 B). Second, we calculated steady state half-lives based on 
the 2-state model (Figure 26 C). These half-lives are based on the time where half the molecules would 
be left starting at steady state rather than after the 1 h pulse. Finally, we calculated the difference in 
half-lives between the two approaches and Schwanhäusser et al (Figure 26 D). We found that, when 
using an exponential assumption for the NED proteins, the reported half-lives were shorter than the 
previously published ones. This is consistent with the fact that the linear regression does not take into 
account that NED proteins stabilize with age. In contrast, the steady state half-lives using the 2-state 
model resulted in a much smaller deviation from Schwanhäusser et al. In summary, using the 2-state 
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Figure 26. Half-life comparison between AHA p-c and Schwanhäusser et al. 
Half-lives derived from AHA p-c were compared to half-lives derived from dynamic SILAC 
measurements in the same cell line (Schwanhäusser et al., 2011). A) ED proteins have similar half-lives 
according to both methods. B) Using an exponential fit when calculating half-lives for NED proteins 
systematically underestimates the half-lives of these proteins. C) Taking the stabilization of NED 
proteins into account by calculating a steady state half-life (see material and methods) gives more 
similar half-lives to dynamic SILAC measurements. D) A direct comparison between half-lives derived 
from an exponential fit and steady state calculations show that steady state half-lives which take the 
2-state model into account give more accurate half-lives. In all panels, half-lives > 300 h were excluded 
because they cannot be accurately calculated with a maximum chase time of 32 h in AHA p-c. Figure 
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3.5.2 SILAC p-c confirms AHA p-c categorization 
Since comparing half-lives is only an indirect test of the non-exponential decay kinetics, we sought to 
directly test this. To this means we developed a method, SILAC pulse-chase (SILAC p-c), which does 
not depend on artificial amino acids and enrichment of newly synthesized proteins. This would limit 
artifacts caused by background binders and impacts of incorporating an artificial amino acid. In the 
SILAC p-c I used fully Light labeled mouse fibroblasts and pulsed them for 4 hours in Heavy SILAC 
DMEM (Figure 27). I then split the cells in two and directly froze one population. The other population 
I switched to Medium-heavy SILAC amino acids and chased the cells for 8 h before harvesting them. I 
then quantified the Heavy/Light ratio before and after the chase. I ignored the Medium-heavy 
population synthesized during the chase. If the new (Heavy) proteins have the same degradation rate 
as the Light pre-existing proteins the H/L ratio should be the same before and after the Medium-Heavy 
pulse. Any changes in the ratio of ratios would indicate NED. For example, the ED protein Lmph2 
showed no difference in the abundance of new (Heavy) and old (Light) proteins after the pulse (ratio 
of ratios 1.02, Figure 27 B). In contrast, the NED protein Psmd2 has less new protein remaining after 
the pulse, indicating that this population is degraded faster than the old population (ratio of ratios 
0.77, Figure 27 C). When looking at all the proteins quantified in one experiment by SILAC p-c (Figure 
27 D), I saw a significant decrease in the newly synthesized protein specifically in the NED population 
as judged by the ratio of ratios.  
In total, I performed 4 experiments with different chase times and labels swaps (see Figure 48 for the 
other 3 experiments). To systematically compare between the different experiments we ranked all 
the proteins in each experiment from the lowest to highest ratio of ratios. We then plotted the 
normalized rank (Figure 27 E) for all the protein categorized as either ED or NED by AHA p-c. We found 
that the NED population was clearly shifted to the lowest ratio of ratios (i.e. having the lowest ranks 
and shifted to the left in the plot). Interestingly, we found a few ED proteins also among the lowest 
ranked ratio of ratios potentially consisting of incorrectly classified NED proteins. This is to be expected 
because we are very conservative with our NED categorization and some NED protein could be 
wrongly classified (Figure 23). From this plot we devised a NED validation score. In total 289 out of the 
331 NED proteins acquired a validation score due to different coverage in the different experiments. 
We considered 200 of the 289 proteins at least partially validated with a validation score of one or 
larger. Importantly, the long pulse times in SILAC p-c impose a strong limit to the sensitivity of this 
assay. Therefore, a lack of confirmation by SILAC p-c should not be interpreted as a false positive in 
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Figure 27. SILAC pulse-chase (p-c) experiments confirm the NED categorization from AHA p-c. 
A) SILAC p-c is based on switching Light cells to Heavy SILAC amino acids. After the Heavy-pulse cells 
are split and one half directly frozen. The other half is chased in Medium-heavy amino acids. By 
comparing the H/L ratio before and after the Medium-heavy-chase one can determine if the 
degradation rate for the old (Light) and new (Heavy) proteins are the same. B and C) MS1 spectra from 
one ED and one NED protein according to AHA p-c before and after the chase. The ED protein lmpdh2 
has the same H/L ratio before and after the pulse. For the NED protein Psmd2 the new proteins have 
been degraded faster than the Light old proteins. D) Showing the ratio of ratios for SILAC p-c for the 
NED, ED and UN protein from AHA p-c. NED proteins have a significantly lower ratio of ratios according 
to a one-sided Wilcoxon sum-rank test comparing the populations to the total (***: p < 0.0001, alpha 
0.05). E) Using the normalized rank from the displayed experiment and the three experiments in Figure 
48 we assigned a validation score for all NED protein. F) Summary of the distribution of validation 
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3.5.3 Radioactive pulse-chase coupled to immunoprecipitation confirms AHA p-c 
profiles 
Finally, we sought to confirm two profiles using the gold standard radioactive pulse-chase coupled to 
immunoprecipitation assay (RIPA). We pulse labeled mouse fibroblasts for 1 h with radioactive 
cysteine and methionine and then chased the cells for 0, 4 or 8 hours. From the same cell lysates we 
immunoprecipitated one ED and one NED protein. We quantified the input using western blot and the 
radioactive signal using a phosphorimager. VCP, an exponentially degraded protein with a half-life of 
more than 100 h in AHA p-c, was found to be very stable also using RIPA. In contrast, Cct3, a NED 
protein according to AHA p-c, showed the expected rapid decay followed by stabilization at 4 h. We 




Figure 28. Radioactive pulse chase of VCP and Cct3. 
NIH 3T3 cells were pulsed with 35S Cysteine and methionine for 1 h before being washed and then 
chased for 4 or 8 h in medium containing 10-fold methionine and cysteine. Cell lysates were split in 
two and incubated with antibodies against the ED protein VCP or the NED protein Cct3. The proteins 
were subsequently enriched before being separated by SDS-PAGE. Proteins were western blotted and 
the membrane was probed with the same primary antibodies as for the IP (“Western blot” in figure). 
The same membrane was also used to expose a magnetic phosphor plate that was then read using a 
phosphorimager. The stable ED protein according to AHA p-c showed no sign of degradation during 
the 8 h of chase. The NED protein Cct3, on the other hand, rapidly decayed to be stabilized by the 4 h 
time point with very little subsequent degradation. Shown is one representative experiment out of 
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3.6 The ubiquitin proteasome system is responsible for some of the 
NED 
Next we sought to uncover the molecular mechanism underlying non-exponential degradation. To this 
means we employed AHA p-c experiments in the presence of small molecule inhibitors or vector 
controls (DMSO) (Figure 29 A). This time we only chased the cells for 4 and 8 hours to be able to 
calculate Δ-scores. We then looked for changes in the Δ-scores after drug treatment compared to the 
control (Figure 29 A).  
Treatment with the proteasome inhibitor MG132 clearly decreased the Δ-score of most NED proteins 
(Figure 29 B and D). In contrast, blocking autophagy had no significant impact on the NED of proteins 
(Figure 29 C and E). This would clearly implicate the ubiquitin proteasome system (UPS) as a main 
degradative pathway responsible for NED. This is consistent with previous findings that newly 
synthesized proteins are mainly degraded by the proteasome (Duttler et al., 2013; Kim et al., 2011; 
Wang et al., 2013).  
Not all proteins were strongly affected by the proteasome inhibition. We therefore performed a GO-
term enrichment analysis for the 20 % of NED proteins (n = 47) which were least impacted by 
proteasome inhibition (Figure 49). We found a significant enrichment of mitochondrial inner 
membrane proteins (n = 13, 3.5 fold enrichment) and mitochondrial proteins (n = 20, 2 fold 
enrichment). This is consistent with the fact that inner mitochondrial proteins are not accessible to 
the proteasome and are thought to be mainly degraded by proteases residing in mitochondria (Tatsuta 
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Figure 29. Blocking the proteasome but not autophagy decreases NED. 
A) Δ-score were calculated by measuring only the 4 and 8 h time points after treatment with small 
molecule inhibitors or control (DMSO). By calculating the net Δ-score (i.e. Treatment Δ-score – Control 
Δ-score) changes in NED can be measured, revealing the molecular mechanism behind NED. B) 
Inhibition of the proteasome using 20 µM MG132 during the chase had a strong and significant effect 
by decreasing the amount of NED, as judged by net Δ-score compared to DMSO-treated control cells. 
The effect was most apparent for the NED proteins. NED, ED and UN are defined from the main AHA 
p-c experiment. C) Blocking autophagy by the addition of 250 nM of the PI3K inhibitor Wortmannin 
and 500 nM of the v-ATPase inhibitor Bafilomycin A1 had no significant effect on NED. D) To control 
for the efficiency of the proteasome inhibitor we monitored the degradation of all proteins as judged 
by the % protein remaining after the different chase times. MG132 clearly stabilized the vast majority 
of proteins, in contrast to DMSO. E) Autophagy blockage was monitored by taking a sample of the cells 
after 8 h chase. The cell lysates were probed by western blotting against β-actin as a loading control 
and for the autophagy marker LC3-II. The cytosolic protein LC3-I is normally conjugated to 
phosphatidylethanolamine to form LC-II that is recruited to membranes of autophagosomes (Tanida 
et al., 2008). LC3-II is then degraded inside the lysosomes. Accumulation of LC3-II is thus a good marker 
of inhibited autophagy. LC3-II is only accumulating when the inhibitors are applied (“Autophagy” in 
plot) but not when DMSO alone is added. p-values are derived from a one-sided Wilcoxon sum-rank 
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3.7 Some NED can be explained by stabilization via complex 
formation 
Since we could confirm the NED of many protein and we had found that the proteasome was mainly 
responsible for their degradation, we next wanted to know what made a protein NED to begin with. 
In this section I will discuss our approaches to determine what makes NED proteins different from ED 
proteins.  
3.7.1 NED proteins are abundant, structured and part of multiprotein complexes 
The first thing we did was to ask if NED proteins have anything in common. We made receiver 
operating characteristics (ROC) curves asking how well we could predict a protein being NED or ED 
dependent on different features. By quantifying the area under the curve (AUC) in ROC-plots one can 
measure if features are a good predictor of a category. An AUC of 0.5 equal random distribution of the 
feature (i.e. no predictive power of the feature on the categorization being tested) while an AUC 
higher than 0.5 indicates a link between the corresponding feature and the applied category. We 
tested a number of features (some displayed in Figure 30) and found a number of features which 
positively predict being a NED protein: high protein abundance at steady state, being part of a 
complex, being structured (high abundance of the secondary structure: helixes and β-sheets) and 
short (lack of length in this case). ED proteins, on the other hand, were enriched in disordered and low 
complexity regions.  
The fact that NED proteins are more abundant than ED proteins could be caused by a technical bias 
because more abundant proteins are also measured more frequently. Being covered by more data 
points correlates positively with being correctly classified as NED (Figure 23). Therefore, some lower 
abundant NED proteins are probably wrongly classified as undefined. However, we did most 
downstream analyses also in a binned manner where we binned proteins based on their cellular 
abundance at steady state and found that the findings below hold true even in this case (not shown). 
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Figure 30. Predicting NED and ED using different features. 
The ability of different protein features to predict ED or NED was tested by measuring the area under 
the curve (AUC) of receiver operating characteristics (ROC) curves. Features can either be present 
(blue) or absent (grey). For example the secondary structure “disorder” is grey for NED proteins 
indicating that NED proteins tend to lack disorder (i.e. they’re more structured) compared to ED and 
UN proteins. Error bars indicate 90 % confidence intervals and are derived from repeating 200 
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3.7.2 NED proteins are enriched in multi-protein complexes  
To confirm the finding from the ROC curves we performed enrichment analysis of the NED proteins in 
two protein complex data bases: PDB (Berman et al., 2000) and CORUM (Ruepp et al., 2008) (Figure 
31). We found a highly significant enrichment in both cases. It was also found that NED proteins are 
preferentially enriched in heteromeric complexes with large number of unique subunits (p = 2.2e-16, 
analysis performed by Joseph Marsh and Jonathan Wells, both at the University of Edinburgh). As a 
control, the PDB analysis was also performed when excluding the ribosome and still found to be 
significant (p = 2.5e-5 against ED, figure not shown). This was done since ribosomes are both very 







Figure 31. NED proteins are enriched in multiprotein complexes. 
NED proteins are enriched in multiprotein complexes both when mapping the categories to A) a 
structural data base (PDB (Berman et al., 2000)) or B) a manually curated protein complex data base 
(CORUM, (Ruepp et al., 2008)). p-values are derived from A) Fisher’s exact test testing heteromeric 
compared to monomeric or homomeric subunits and B) hypergeometric test testing enrichments 
relative to the total population (“All” in figure).  Panel A) courtesy of Joseph A. Marsh and Jonathan N. 
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3.7.3 NED proteins have larger interfaces within complexes and assemble earlier 
Even though we found a strong enrichment for NED proteins in multiprotein complexes, these also 
contain ED proteins. We therefore asked if there are differences between the two populations within 
complexes. We found that NED proteins tend on average to have a larger interface towards other 
proteins in a complex (Figure 32). This would indicate that NED proteins are more buried inside a 
complex than their ED counterparts. Since complexes have a determined evolutionary conserved 
pathway to assemble, we then looked into whether NED proteins tended to assemble in a specific 
manner (Marsh et al., 2013). We found that NED proteins tend to assemble earlier than ED proteins 
in the same complex. These two findings would indicate that NED proteins are “core” members in 
complexes, making up a “founding” set of proteins on which the ED proteins attach. To further test 
this hypothesis we looked at mRNA co-expression data and found that NED proteins are strongly co-
expressed with other NED proteins whilst ED proteins are only weakly co-expressed with the other 
members of the same complex (data not shown), supporting the idea that NED proteins are indeed 
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Figure 32. NED proteins have larger interfaces in complexes and assemble earlier. 
A) NED proteins have larger interfaces than ED proteins in complexes. The interface size between the 
protein and other proteins in the same complex was calculated in square Ångström based on the 
crystal structure for the complex. Complexes are binned for the number of unique subunits to counter 
the fact that NED proteins are especially enriched in complexes with a large number of subunits. The 
number of proteins in each bin is annotated at the bottom of the panel. B) Protein complexes are 
assembled in an ordered manner (Marsh et al., 2013). Proteins were ranked from 0, the first protein 
in the complex, to 1, the last protein to assemble in the complex. Then, the normalized assembly order 
was calculated for the three different categories of proteins. Subunit counts are given in each boxplot. 
All p-values are derived from Wilcoxon rank-sum tests. Analysis courtesy of Joseph A. Marsh and 
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3.7.4 NED proteins are produced in super-stoichiometric amounts 
The idea that complex formation could stabilize protein subunits has been around for a long time 
(Goldberg, 2003; Kuriyama and Omura, 1971). Several individual examples support this hypothesis 
(Blikstad et al., 1983; Johnson et al., 1998; Lam YW, 2007; Minami et al., 1987; Shemorry et al., 2013; 
Toyama et al., 2013). Complex formation could explain some cases of non-exponential degradation: if 
NED proteins were produced in excess relative to ED proteins, the degradation of the non-assembled 
subunits would lead to non-exponential decay (Figure 33 A). Based on the fact that complexes contain 
both NED and ED proteins, we hypothesized that NED proteins must be made in super stoichiometric 
amounts relative to the ED proteins in the same complex. We therefore analysed the abundance of 
newly synthesized proteins directly after the pulse. We then looked in a complex-centric manner to 
see if the NED proteins were synthesized in excess (Figure 33 B). We found that this was indeed the 
case. The prediction also held true (although not statistically significant) when we looked at an 
independent ribosome profiling dataset (Subtelny et al., 2014) (Figure 33 C). In conclusion, two 
different methods support the simple model that NED proteins are made in super-stoichiometric 
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Figure 33. NED proteins are over synthesized compared to other proteins in the same complex. 
A) A simple model can explain NED of proteins in complexes. NED proteins (turquoise in figure) are 
synthesized in super-stoichiometric amounts compared to the ED proteins (red) in the same complex. 
Excess NED proteins that do not make it into the complex are then degraded. B) Normalized iBAQ 
values were calculated for all proteins based on the Heavy SILAC label in the AHA p-c experiment (i.e. 
the abundance after pulse). The relative abundance after pulse was then calculated in a complex-
centric manner. NED proteins were found to have a higher relative abundance than ED proteins in the 
same complex. C) The same as in B but this time ribosome profiling data from the same cell line was 
used (Subtelny et al., 2014). p-values are based on a one-sided Wilcoxon rank-sum tests (ED vs. NED). 
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3.7.5 NED and ED degradation rates support the stabilization by complex 
formation model 
Our hypothesis states that NED proteins that are part of multiprotein complexes are synthesized in 
super-stoichiometric amounts and that the proteins that do not make it into a complex are degraded. 
This hypothesis allows another prediction. NED proteins have two degradation rates, kA and kB, 
representing the degradation rates from the two states A and B (Figure 34 A). State A in our hypothesis 
represents the free (or partially assembled) subunit and state B represents the subunit within a fully 
assembled complex. The ED proteins, on the other hand, only have one state and one exponential 
degradation rate, which would represent being in a complex. We can therefore predict that the second 
state of the NED proteins should have a degradation rate similar to the degradation rate of the only 
state for the ED proteins since both would be the degradation rate of the complex. To test this we 
plotted the degradation rate for state A and B for the NED protein and the exponential degradation 
rate for the ED protein for a number of complexes (Figure 34 B-H). We found that the degradation 
rate kB was in all cases more similar to the ED proteins exponential degradation rate than the kA for 
the NED proteins. In summary, our finding that the degradation rates for the second state of NED 
proteins are similar to the exponential degradation rates of the ED proteins in the same complex 
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Figure 34. Degradation rates for NED proteins tend to be similar to the degradation rates of ED proteins in the 
same complex.  
A) The two models used to determine degradation profiles. NED proteins are represented by the 2-state model 
and ED proteins by the 1-state model. B-H) Degradation rates for the NED state A (kA) and state B (kB) in addition 
to the exponential degradation rate of the ED proteins within the annotated complexes are displayed. In the 
case of NED the same protein is always plotted twice (indicated by the arrow) before and after the transition to 
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3.7.6 Prevention of ribosome assembly increases NED of ribosomal subunits 
To more directly test our observation we performed an experiment with the same setup as for the 
degradation inhibitors. We used the small molecule inhibitor Actinomycin D, which at low doses 
inhibits primarily ribosomal RNA (rRNA) synthesis by RNA Polymerase 1 (Bensaude, 2011; Jao and 
Salic, 2008). Blocking synthesis of rRNA subsequently prevents ribosome assembly (Andersen et al., 
2005; Girard et al., 1964; Warner, 1966; Warner, 1977). We reasoned that an increased competition 
for assembly would increase the pool of free unassembled subunits, thereby increasing the measured 
NED. Our prediction held true and we found increased Δ-scores specifically for ribosomal proteins 
after treatment (Figure 35), consistent with previous data (Lam YW, 2007; Warner, 1977). It is worth 
noting that the apparent high stability of ribosomal proteins and other proteins in complexes using 
dynamic SILAC or cycloheximide chase methods is not in conflict with these findings. Rather, it can be 
well explained by our model since we find that at steady state the vast majority of proteins are in state 
B, in other words, in the complexed stable form (Figure 50).    
 
 
Figure 35. Actinomycin D treatment prevents ribosome assembly and increases NED of ribosomal proteins. 
The AHA p-c experiment was performed as in Figure 29. NIH 3T3 cells were treated with either 100 
nM Actinomycin D or DMSO (Control) during the pulse and chase. Net Δ-scores were calculated as in 
Figure 29. Ribosomal proteins have a large increase in Δ-scores indicating that prevention of complex 
assembly increases the number of proteins in the first state with a higher degradation rate. Statistics 
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3.8 NED is an evolutionarily conserved property 
One worry with our finding that super stoichiometric production of proteins in complexes cause non-
exponential degradation is the model system we used for our initial findings. The NIH 3T3 mouse 
fibroblasts are mainly tetraploid but have a complex karyotype with frequent further amplification 
and deletions (Leibiger et al., 2013). In total, less than 2 % of the NIH 3T3 cell genome is disomic. The 
over-synthesis could therefore be an artifact of our model system in which amplified regions cause 
increased protein levels, inducing the NED of proteins that are uncoordinatedly produced. We 
therefore set out to perform AHA p-c experiments in a disomic cell line with limited karyotype issues.    
3.8.1 Whole genome sequencing of RPE-1 cells 
We turned to the disomic human retinal pigmented epithelial cell line (RPE-1) (Stingele et al., 2012). 
To confirm that this cell line indeed is disomic we performed low coverage whole genome sequencing 
(Figure 36). We found that, except for a partial trisomy of chromosome 10 and clonal expansion of a 
population with trisomy of chromosome 12, the cell line was mainly disomic. We therefore continued 




Figure 36. Low coverage whole genome sequencing of the RPE-1 cell line reveals a mainly disomic karyotype. 
A library of RPE-1 cell genomic DNA was created and sequenced with a depth of about 30 million reads 
(see material and methods). Displayed are the genomic copy numbers over the chromosomes. 
Sequencing and figure courtesy of Xi Wang, Jingyi Hou and Wei Chen (MDC). Cell line and sample 
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3.8.2 AHA p-c of human RPE-1 cells 
After confirming the mainly disomic nature of the RPE-1 cells, we set out to perform AHA p-c 
experiments. We performed three biological replicates and used the same data processing pipeline as 
for the mouse fibroblast cells (Figure 37). All in all, the human numbers were similar to the mouse 
fibroblasts, with 1474 ED (47 %), 1363 UN and 296 NED (8 %) out of the 3133 profiles passing all of our 
quality criteria. Taken together, AHA p-c experiments of a human disomic cell line show that the 
number of NED proteins is not mainly dependent on the chromosomal aberration of the mouse 









Figure 37. Overview of data processing and quality for AHA p-c experiments using RPE-1 cells. 
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3.8.3 NED is conserved between mouse and human 
Since we now had data on non-exponential degradation from two different species, we realized that 
we could find out the level of evolutionary conservation of NED. First, we mapped the mouse orthologs 
to their human counterparts. We then asked if there was an enrichment for human ED proteins among 
the mouse ED proteins and of human NED proteins among mouse NED proteins (Figure 38 A). In both 
cases we found a very significant enrichment. 
We then turned to the Δ-scores to ask if there was a correlation between the human Δ-scores and the 
Δ-scores of their mouse orthologs (Figure 38 B). Once again we found a highly significant correlation. 
From these data we conclude that NED is at least partially evolutionarily conserved between mouse 
and human and also consistent between different cell types.     
 
 
Figure 38. NED is conserved between human and mouse. 
Human proteins were mapped to their mouse orthologs. A) Displaying the fraction of proteins being 
categorized as NED, ED or UN in human. From the left; all the protein as categorized in Figure 37, 
second the same categories when looking only at the portion of the human proteins mappable to their 
mouse orthologs. Third, using only the proteins defined as ED from mouse and finally using the NED 
proteins from mouse. p-values are based on a hypergeometric test. B) Significant correlation between 
human and mouse ortholog Δ-scores. Proteins were mapped as in A) but this time Δ-scores were 
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3.8.4 Super-stoichiometric synthesis of NED proteins is evolutionarily conserved 
Finding an evolutionary conservation of NED between mouse and human cells, we turned back to the 
hypothesis regarding over-synthesis of NED members of protein complexes. We wanted to see if the 
over-synthesis also was conserved as this would strongly support the model we put forward. We 
therefore once again performed the protein-centric analysis as shown in Figure 33. Looking at the 
protein abundance after pulse in the human cells we again found that NED proteins were synthesized 
in higher amounts relative to the ED proteins in the same complex (Figure 39 A). This held true also 
when we used the mouse definitions mapped back to the human orthologs, indicating that the same 
proteins are over-synthesized in mouse and human. To further test the hypothesis and to exclude any 
potential mass spectrometry-derived artifacts, we turned to previously published ribosome profiling 
datasets and mapped the human definitions to them (Figure 39 B). We found an evolutionarily 
conserved over-synthesis of NED proteins in mouse and zebrafish and the same trend, although not 
significant, also for worm. From these two analyses we conclude that our model in which NED proteins 




Figure 39. Super stoichiometric synthesis of NED protein is evolutionarily conserved. 
A) The analysis of the AHA p-c experiments using human RPE-1 cells was performed as in Figure 33. 
NED proteins are over-synthesized in human cell using either the human or mouse categorization of 
NED, ED and UN. B) As in A) but using ribosome profiling (RPF) data from human (Liu et al., 2013), 
mouse (Shalgi et al., 2013), zebrafish (Chew et al., 2013) and worm (Nedialkova and Leidel, 2015). In 
all cases the NED population has more RPF reads (see material and methods). p-values are derived 
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3.9 NED predicts attenuation in aneuploidy 
Learning that NED proteins are produced in super-stoichiometric amounts we wondered what would 
happen if one modified the levels of newly synthesized NED proteins. We would predict that increasing 
synthesis levels of a NED protein would not increase the steady state level of that protein since the 
excess proteins would be degraded (Figure 40). Importantly, the model we propose would allow one 
to make predictions regarding steady state protein levels in aneuploidies. Aneuploidy is a frequent 
cause for birth defects such as mental retardation and spontaneous abortions and is one of the 
hallmarks of cancer (Hassold et al., 2007; Santaguida and Amon, 2015). Interestingly, for a number of 
proteins derived from amplified genes in aneuploid cells steady state levels do not increase as much 
as expected (Dephoure et al., 2014; Torres et al., 2007). This is the case even though transcript levels 
are elevated for these proteins, indicating posttranscriptional regulation. The concept of protein 
abundances regressing to diploid levels in aneuploidy cells has been termed attenuation. Attenuation 
has been noted to be more common for proteins in multi-subunit complexes (Dephoure et al., 2014; 
Geiger et al., 2010; Stingele et al., 2012).  
We would expect that attenuation can be predicted using our acquired degradation profiles. To test if 
our hypothesis is correct and if we have a better predictive ability than the simpler hypothesis that 
proteins in multiprotein complexes are attenuated we turned to an aneuploidy cell model. We 
acquired RPE-1 cells that had an extra copy of chromosome 5 generated by microcell-mediated 
chromosome transfer, referred to as RPE-1 trisomic cells below (Stingele et al., 2012). This model had 
the added benefit that we could use the parental RPE-1 cell line as a direct control. 
 
Figure 40. The simple super stoichiometric synthesis model allows for testable predictions. 
We predict that increased synthesis of a NED protein caused by aneuploidy would not lead to 
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3.9.1 RPE-1 trisomic cells: sequencing and chromosome paints 
We first sought to characterize the trisomic cell line and once again performed low coverage whole 
genome sequencing (Figure 41). We found that, in contrast to the parental cell line, the trisomic cell 
line had an extra copy of chromosome 5 and also a partial trisomy of chromosome 11. The partial 
trisomies as well as the trisomy of chromosome 12 were all acquired spontaneously by the cell lines. 
To confirm the sequencing results we performed chromosome painting (see material and methods) 
and found that the trisomy of chromosome 5 and a translocation event coupling part of chromosome 
11 to an unidentified chromosome were unique to the trisomic cell line (Figure 41). Since chromosome 
12 and parts of chromosome 10 were amplified in both the trisomic and parental cell lines, they were 
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Figure 41. Low coverage whole genome sequencing and chromosome paints of the RPE-1 trisomic cell.  
A) Genome sequencing was performed as in Figure 36. B) Chromosome paints reveal a trisomy of 
chromosome 5 and parts of chromosome 11 that have been amplified and fused to an unknown 
chromosome in the RPE-1 trisomic cell line. Cell line, sample preparation and chromosome paints by 
Neysan Donnelly and Zuzana Storchova (MPI for Biochemistry). Sequencing and plot courtesy of Xi 
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3.9.2 Genomic amplification leads to increased levels of newly synthesized 
proteins 
Next we performed AHA p-c experiments with three biological replicates of the RPE- trisomic cell line. 
We then calculated the abundance of newly synthesized proteins after the pulse in these cells (Figure 
42). We found that proteins encoded on the trisomic regions were significantly more abundant than 
their disomic counter parts after the pulse. Indicating an increased protein synthesis of protein 
encoded on trisomic regions. These finding confirm the whole genome sequencing analysis and show 







Figure 42. Genomic amplification leads to increase in newly synthesized protein levels. 
iBAQ values for proteins after the pulse (Heavy intensities, time point 0 h) were calculated for the RPE-
1 and RPE-1 trisomic cell lines. Then log2 fold changes were calculated for each protein. The proteins 
are ranked according to their chromosomal position. Trisomic regions are highlighted in orange, 
disomic regions in blue and grey indicates ambiguous regions with amplifications in both the parental 
and trisomic cells. The moving average is highlighted as an orange line. Regions with significantly 
different fold changes compared to the parental cells are shown with asterisks. ***: p < 0.0001 
according to a one-sided Wilcoxon sum-rank test (alpha = 0.05). Analysis and figure courtesy of Henrik 
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3.9.3 Over-synthesis of NED proteins lead to increased NED  
Our model predicted that over-synthesized NED protein would become more NED if the abundance 
of newly synthesized proteins increased. To test this we calculated Δ-scores for the proteins in the 
RPE-1 trisomic cell line and compared them to the parental cell line (Figure 43). We found that there 
was a significant increase in the Δ-score of NED protein encoded on trisomic chromosomes. In 
contrast, ED proteins showed no increase in non-exponentiality when over-expressed. This would 







Figure 43. Δ-scores of NED proteins increase after genomic amplification of the respective genes. 
Net Δ-scores are displayed comparing NED and ED proteins encoded on trisomic regions (as defined 
in Figure 42) and disomic proteins. NED proteins show a significant increase in Δ-scores when derived 
from genomically amplified regions as determined by a one-sided Wilcoxon sum-rank test. In contrast, 
ED proteins encoded on the same regions show no increase in NED as determined by Δ-scores. Analysis 
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3.9.4 NED predict attenuation at steady state in trisomic cells 
Since protein level attenuation in aneuploidy has previously been mainly explained by complex 
formation, we wanted to see if NED would be a better predictor of attenuation. We therefore 
performed a standard SILAC experiment to measure the relative protein levels RPE-1 and RPE-1 
trisomic cells at steady state. We then mapped our NED categorization to the quantified proteins 
(Figure 44). We found that ED proteins encoded on trisomic regions were increased at steady state. 
NED proteins however, were found at lower levels than ED proteins. This held true also when we 
compared proteins defined as being in a complex or proteins not in a complex. We conclude that NED 







   
Figure 44. NED proteins are more attenuated than ED proteins in trisomic RPE-1 cells. 
Displayed are steady state protein fold changes comparing RPE-1 and RPE-1 trisomic cells. ED proteins 
are more elevated than NED proteins when looking at A) all proteins, B) proteins in a complex and C) 
proteins not in the CORUM database. Statistics are from a one-sided Wilcoxon sum-rank test. Analysis 
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4 Discussion 
I will here summarize the main findings and try to put them in perspective. I will take some time to 
discuss the technical limits of AHA p-c because an understanding of the shortcomings of the method 
is crucial in interpreting the data. Finally, I will discuss the biological implications of our findings.   
4.1 Summary of findings 
To evaluate changes in protein degradation kinetics as proteins age we developed a global pule-chase 
method. We combined SILAC labeling with pulse and chase by the non-canonical amino acid 
azidohomoalanine. Using LC-MS/MS we then determined the degradation profiles for thousands of 
proteins. Applying Markov chain-based modeling we determined the propensity of different proteins 
to show NED. Our major finding is that NED is common with at least 10 % of proteins showing this type 
of decay pattern (see Figure 45). This means that the common assumption of exponential degradation 
is not always correct. We further found that NED is mainly executed by ubiquitin proteasome system. 
In addition, a great deal of NED could potentially be explained by the super-stoichiometric production 
of protein complex subunits. In our simple model, the excess subunits that do not make it into a 
complex are then degraded. Furthermore, within the same complex different proteins show NED and 
ED with the NED proteins tending to be shorter and more structured. Interestingly, the same proteins 
are on average overproduced in different species, indicating evolutionary conservation. Finally, we 
found that further increasing the levels of newly synthesized NED proteins did not translate to 
increased steady state levels of these proteins. Thereby, we can use our NED categorizations to predict 
attenuation in aneuploidy.  
 
Figure 45. Summary of NED categorization. 
Applying both a cut-off of the AIC probability and the Δ-score we defined 10 % of proteins in NIH3T3 
mouse fibroblasts as NED. 
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4.2 Limitations of the method 
Even though AHA p-c allows a novel understanding of cell biology, it is important to keep in mind its 
limitations. I will below discuss the major potential caveats when applying AHA p-c 
4.2.1 Azidohomoalanine is an unnatural amino acid 
Azidohomoalanine is an unnatural amino acid and the cell distinguishes between it and methionine 
(Kiick et al., 2002). This is in sharp contrast to stable isotope encoded amino acids which are virtually 
indistinguishable from standard amino acids for the cells.  
One effect of AHA-labeling is decreased protein synthesis (Figure 11) (Bagert et al., 2014). Cells seems 
to respond to AHA-labeling by an amino acid starvation response e.g. by decreasing biogenesis of 
ribosomes. The effect is not caused by incorporation of AHA itself because when methionine and AHA 
are used concurrently, the effects on protein synthesis are gone, even though AHA has been 
incorporated into proteins (Bagert et al., 2014). Another complicating factor is that titrating in higher 
concentrations of AHA does not further increase protein synthesis (Figure 11 A). These issues indicate 
that:  
 AHA does not fully compensate for the lack of methionine in the cells  
o Perhaps reflecting a methionine sensor in the cell incapable of recognizing AHA 
(Efeyan et al., 2012) 
o Or the lack of other functions of methionine in cells such as methionine being the 
starting material for DNA methylation 
 there exist a rate limiting process during the AHA labeling  
o Possibly the loading of methionyl-tRNA (Kiick et al., 2002). 
One strategy we deployed to alleviate the effects on proteins synthesis was to limit the pulse time to 
1 hour. This minimizes the starvation sensed by the cells to a total of 2 h when including the 1 h 
methionine depletion before the AHA-pulse. When using a 1 h AHA-pulse we reach roughly 90 % of 
the expected protein synthesis during the pulse (Figure 13).  
Another issue is that we cannot fully exclude some impact of AHA-incorporation on protein stability, 
even though the radioactive experiments, RIPA experiment, half-life experiment and the current 
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2013; tom Dieck et al., 2015). I will in the following segment discuss a special case of potential issues 
of AHA-labeling on protein degradation kinetics.  
4.2.1.1 Exchanging the N-terminal methionine with AHA 
That AHA substitutes methionine in proteins comes with many benefits such as the fact that 
methionine is a frequently used amino acid. However, it also creates its own set of unique challenges. 
Chiefly, the main difference between methionine and other amino acids is that the first amino acid 
incorporated into newly synthesized proteins is the initiator methionine (encoded by the start codon 
AUG). Moreover, the amino acids at the amino terminus of proteins are thought to be an important 
factor that determines protein stability. Since AHA is incorporated instead of methionine, the potential 
impact of this artificial amino acid on protein degradation needs to be considered in this context. 
The effect of N-terminal amino acids on the half-life of a protein in yeast was reported by the 
Varshavsky lab (Bachmair et al., 1986), where they created a ubiquitin-β-gal fusion expression vector. 
Since ubiquitin is commonly expressed as a fusion protein, there exist cellular proteases responsible 
for the separation of ubiquitin with its co-synthesized neighbor (Baker et al., 1992). Varshavsky took 
advantage of this and created 20 different ubiquitin-β-gal mutants only differing in the N-terminal 
amino acid. Ubiquitin was cleaved off in vivo and consequently β-gal with different N-terminal residues 
was produced. Strikingly, the different mutants had very different half-lives, ranging from >20 h for 
methionine to 2 minutes for arginine. From this finding the lab proposed the “N-end rule”, which 
states that the N-terminal amino acid regulates the half-life of a protein. The N-end rule was later 
refined (and complicated) by the Ac/N-end rule (for N-terminally acetylated eukaryotic proteins), 
Arg/N-end rule (for non-acetylated proteins) and the mitochondrial N-end rule (Shemorry et al., 2013; 
Varshavsky, 2011).  
Most cellular proteins are at least partially N-terminally acetylated in human cells (Arnesen et al., 
2009; Harper and Bennett, 2016). Interestingly, the Varshavsky lab demonstrated that Cog1 and Hcn1 
were both degraded after an acetylated N-terminal methionine functioned as a degradation signal, 
also known as a “degron” (Shemorry et al., 2013). However, when the proteins were in their 
complexed form in the “conserved oligomeric Golgi complex” and “anaphase-promoting complex” 
respectively, the degron was shielded by the interaction and the proteins were stabilized. 
Theoretically, this molecular mechanism could explain many cases of NED. However, we still see NED 
even when it can be assumed that many N-terminal methionines have been replaced by AHA (Bagert 
et al., 2014). To further elucidate the relevance of the Ac/N-end rule in NED, it would be relevant to 
find out how many of the N-terminal methionines have been replaced. It would also be interesting to 
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knock-out Doa10, the E3 ubiquitin ligase responsible for targeting the Ac/N-end substrates for 
destruction (Shemorry et al., 2013). 
It could also be speculated that some NED detected by our method is an artifact caused by the creation 
of a population of proteins which lack the destabilizing N-terminal methionine acetylation and 
therefore are stabilized by the N-terminal AHA-incorporation. In this case, two lines of evidence – the 
SILAC p-c experiment and the fact that we report similar to previously published protein half-lives – 
point to a limited impact of replacing N-terminal methionines with AHA. This is in line with the fact 
that the relevance of the Ac/N-end rule has recently been questioned (Boisvert et al., 2012).  
Finally, the full removal of the N-terminal methionine is a common co-translational modifications 
(Varland et al., 2015). Two further issues related to N-terminal AHA-incorporation are instigated by 
the excision of the initiator methionine:  
 First, the excision of the N-terminal amino acid is less effective when methionine has been 
replaced by AHA (Bradshaw et al., 1998; Wiltschi et al., 2009). This could lead to the creation 
of two populations one with and one without the second amino acid after the initial amino 
acid exposed.  
 Second, another scenario is when a protein species only incorporate one AHA molecule on 
average (e.g. very short proteins during suboptimal labeling conditions). Imagine that a 
protein contains two methionines which of one is the initiator methionine. If half of these 
proteins contain an AHA only at the initiator position and the other half an internal AHA it 
would look like half with the initiator-AHA display rapid degradation kinetics due to the quick 
removal of the said initiator-AHA. This is because when we lose the only AHA we could use to 
enrich the protein with it appears like it has been degraded in our assay.  
However, as discussed above, the fact that we see NED in SILAC p-c experiments suggests a limited 
impact of such artefacts. In addition, we decreased NED by inhibiting the proteasome with MG132. 
This compound should not inhibit the methionine aminopeptidases 1 and 2, which are responsible for 
the N-terminal methionine excision. The strong effect of MG132 limits the possibility that we have 
wrongly categorized proteins as NED in cases where the initiator-AHA or a short signal peptide is 
cleaved off. In addition, with a one hour long pulse most co-translation effects are probably too fast 
for our assay to detect. 
In summary, most N-terminal methionine related issues are probably controlled for with the SILAC p-
c experiments and the half-life analyses but we cannot fully exclude all potential artefacts caused by 
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4.2.2 Background binding to the alkyne-beads 
As with all enrichment based methods, there is a risk that background binding could distort the results. 
This would be especially problematic in our assay because background binding could mimic non-
exponential degradation profiles for rapidly degraded proteins. This is because when we have 
consistent background binding, consider for example a scenario where 20 % of the signal is 
background, a protein cannot go below this value. If a protein would be fully degraded the signal would 
only drop to 20 % (background level) and then remain at this level which we would interpret as a 
biologically relevant stabilization of this protein. This potential “artificial stabilization” of proteins is of 
concern and below I will discuss our strategies for controlling for such events.    
Our control experiments indicate that we have a surprisingly consistent background binding (Figure 
24 C). Interestingly, we found that background binders were enriched for more hydrophobic amino 
acids and contained more reactive amino acids like cysteine and serine (data not shown). A potential 
model for background binding is that more hydrophobic proteins interact more with the beads and 
that this allows for improper covalent linking of reactive amino acids to the alkyne moiety. In any case, 
the consistent background binding allowed us to control for the impact of background binding. We 
found that after subtracting background levels from the control experiment from the proteins in the 
AHA p-c experiment we still categorized the NED protein as NED proteins (Figure 25).  
Our main approach to handling background binding (and SILAC ratio compression) was to exclude data 
points in the “danger zone” below 10 %. This is because the background binding control experiments 
indicated that the vast majority of proteins do not show background binding above this limit (Figure 
24). It is also worth noting that most NED proteins stabilize much above this limit (median 47 and 41 % 
protein remaining at the 4 and 8 h time point respectively) and that very few proteins display 
background binding close to these numbers. 
In addition, if background binding is causing artificial stabilization of NED proteins, the later time 
points would not reflect biology but rather only reflect background binding. Therefore, we calculated 
half-lives assuming exponential degradation using data derived only from the first 4 h for NED proteins 
(not shown). This would model a scenario where the protein is rapidly degraded followed by artificial 
stabilization. Half-lives computed from only the early time points correlated very poorly and were 
much shorter than previously published half-lives. This observation indicates that proteins do indeed 
stabilize at later time points. Thus, the stabilization of NED proteins in the AHA p-c data does not seem 
to be due to background binding.      
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All in all, the fact that most NED proteins could be confirmed by SILAC p-c a method not dependent 
on enrichment – limits the impact of the enrichment process on creating false positives (Figure 27). 
Nevertheless, not all NED proteins could be confirmed by SILAC p-c because either they were not 
covered or did not show NED in the SILAC p-c experiments. The SILAC p-c experiments are based on 
very long pulses and thereby suffer from a lower sensitivity than AHA p-c. Therefore, a lack of 
confirmation by SILAC p-c does not mean a false positive NED protein but just that it is unconfirmed. 
Further research is needed to uncover the false positive rate of AHA p-c in categorizing NED proteins.  
4.2.3 Assumption related to normalization procedure 
To alleviate issues regarding different labeling efficacy, starting material and pipetting errors, we 
needed to normalize the data. All normalization procedures depend on assumptions. In our case, the 
assumption is that certain proteins are fully stable. Although this assumption is probably not fully 
realistic, there are many literature examples of proteins with extremely long half-lives e.g. (Toyama et 
al., 2013). We found that using between 30 – 200 LSD proteins gave very consistent normalization 
factors, indicating that many proteins in our assay are very stable. In fact, our LSD normalization 
proteins contain many known stable proteins commonly used for input normalization, such as β-actin 
and GAPDH. The fact that the LSD-protein based normalization yields half-lives similar to those in 
previous publications is also comforting (Figure 26).  
Importantly, the degradation profiles per se are quite independent of the normalization factors, i.e. 
changing the number of LSD proteins increased or decreased the average reported half-life but had a 
very limited impact on the NED/ED categorization (data not shown). This is because the degradation 
profile of a protein is relative to the degradation profile of all other proteins in the same experiment. 
Shifting all data points by a multiplicative normalization factor does not shift the relative position of 
the data points. 
4.2.4 Compromises regarding pulse and chase length 
Perhaps the most important limitation of AHA p-c is the pulse-length. The pulse length is a compromise 
between the:  
 Depth of the analysis 
o Shorter pulses decrease the number of identified proteins drastically  
 Amount of background binding  
o The ratio of labeled to unlabeled proteins increases with pulse length 
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o Shorter pulses allow a more detailed resolution of degradation kinetics. For example, 
most co-translational degradation can be assumed to be undetected in our assay since 
after the 1 h long pulse most co-translated proteins are already degraded and we 
would not be able to detect a drop in protein levels (Duttler et al., 2013).  
Conversely, the chase length also limits the analysis. We limited the longest chase time point to 32 
hours. This was done to avoid the cells reaching full confluency during the experiments, which can be 
expected to change the degradation kinetics, since the cells go from exponential growth mode to 
stationary phase. Therefore, we cannot say anything about kinetic changes taking place after 32 h of 
chase. For example, we are not able to identify proteins that become destabilized after that time 
(Young and Bok, 1969). It is worth noting that most of the initial degradation from state A has taken 
place at around 1-4 h, indicating that chasing much longer than 8 h to capture protein stabilization is 
probably not necessary for the majority of NED proteins. Therefore, we also limited the analysis to 4 
and 8 h time points in the inhibitor-treated cells.  
4.2.5 Limitations related to the modeling approach 
The more time points that are sampled, the more advanced models can be applied without risking 
over fitting the data (Burnham K.P., 2002). For example, studies looking at mRNA degradation 
commonly use more sampled time points and more complicated multi step models (Deneke et al., 
2013; Sin et al., 2016). In this study, we limited the number of time points to 7 because of the triple 
SILAC approach, in which we needed to add one experiment and more machine time with each two 
time points added (time point 0 h is always present), quickly increasing the amount of work needed. 
It is interesting that these two simple models could fit the data quite well. In fact, very few proteins 
were excluded by the lack of fit to either model (not shown).  
Finally, regarding the model, we interpret the model outcome as an ageing of individual proteins. 
However, the two state model applied does not distinguish between that scenario and a scenario in 
which proteins are “born” into two different states and that these two states have different 
degradation rates (Aalen, 1994). One such scenario could be that proteins are either mistranslated or 
correctly translated, where the mistranslated proteins would have a higher degradation rate. 
4.2.6 Abundance bias  
The more data points we collected, the more certain we can be when categorizing a NED protein. This 
means that more abundant and thereby better covered proteins are more likely to correctly be 
categorized as NED. Until we have full coverage of the proteome with AHA p-c this bias will to some 
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extent, remain. To minimize the impact of the abundance bias we performed most analyses in a 
protein complex-centric manner. Since most complex subunits are expressed at similar levels, this bias 
is alleviated. 
4.3 Biological implications of NED degradation 
Taking the caveats discussed above into account we can turn to the biological function of NED. I will 
here discuss the historic reasons for the general assumption of exponential degradation still remaining 
to date. I will then turn to the reasons for proteins to be degraded by non-exponential kinetics. Finally, 
I will discuss the implications of this in the context of aneuploidy and in cancer. 
4.3.1 Where does the assumption of exponential degradation come from?  
There are a number of reasons why exponential degradation became the way to describe protein 
degradation. Probably the main reason is the fact that it is a simple and convenient term to discuss 
turnover. However, it should be noted that at the time when exponential degradation became the 
paradigm the possibility to detect NED was limited. For example, all the proteins referred to in Robert 
Schimke’s seminal 1970 review paper “Control of enzyme levels in animals”, with the exception of 
ferritin, were enzymes (Schimke and Doyle, 1970). From this publication, which is probably the best 
summary of known half-lives at the time, it is clear that: 
1. There are only a handful of enzymes with a described half-life. 
2. The vast majority of listed proteins are active as monomers or homomeric complexes. In other 
words, they are not members of heteromeric complexes, which are the main component of 
the NED population. Consistently, the proteins with one exception are ED or undefined also 
in this study. Interestingly, the only exception, ferritin, was actually shown to display NED in 
the presence of iron (see Figure 46 (Drysdale and Munro, 1966)). 
3. Most kinetic analysis methods (e.g. Figure 47) were not suitable for detection of NED. Even 
though many studies used gold standard radioactive pulse-chase methodology the use of 
whole animals, imprecise enrichment techniques and suboptimal time points severely limited 
the ability to find anything other than ED. 
Most of the above points can be explained by a detection bias. When the first enzyme, Urease, was 
crystalized and showed to be a protein, it opened up a whole new line of research (Sumner, 1926). 
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biochemical separation methods, it was now possible to estimate the enrichment factor by testing for 
enzyme activity (e.g. (Archibald, 1945; Price et al., 1962; Schimke, 1964)).  
This, however, led to that only enzymes with known chemical reactions could be monitored. Even 
after the advent of immunological enrichment methods the detection bias remained because the only 
way to create the antibodies to begin with was to immunize animals with enriched protein e.g. known 
enzymes. The low numbers of measured half-lives and the monomeric/homomeric nature of the 
measured proteins are both derived from the requirement of known biochemistry for each enzyme 
and to the limitation in enrichment techniques. When these requirements were relaxed the variation 







Figure 46. Turnover of rat liver ferritin after injection of Leucine 14C from (Drysdale and Munro, 1966).  
Baseline Ferritin (Control) or higher levels of ferritin were induced by either single or repeated doses 
of 400 µg iron. After animals were sacrificed at indicated times, the specific radioactivity of ferritin 
(enriched by chromatographic isolation) was measured. The control ferritin showed exponential 
degradation, whilst the addition of iron stabilized a population of ferritin, leading to a non-exponential 
behaviour. The authors conclude “The injected iron might act at the time of protein synthesis, prevent 
breakdown of nascent ferritin by stabilization of an unstable precursor”. Reproduced with permission 
from publisher.  
 




   97 | P a g e  
 
 
Figure 47. A common way to estimate protein turnover was by enzyme kinetics.  
Example from (Tarentino et al., 1966), where rats where treated with thyroid hormone (T4) for 10 
days to induce maximum levels of malate dehydrogenase and α-glycerophosphate dehydrogenase. At 
day 0 the animals are taken off thyroid hormone and are instead treated with ethionine, which 
prevents induction of the enzymes. Rats where sacrificed at indicated days and liver homogenates 
where prepared and enzyme activity was measured. Although a clear exponential fit can be seen, it’s 
quite obvious that this method is not optimal for detecting non-exponential degradation because the 
“chase” starts with the whole steady state population of the proteins and not a younger age-defined 
population. In other words, the “pulse” is much too long to detect age-dependent changes in 
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4.3.2 Why are proteins non-exponentially degradaded? 
As mentioned in the introduction, few individual proteins were known to show non-exponential 
degradation kinetics before this thesis. The two proteins mentioned, Basigin and CFTR, are both 
substrates of ER-associated protein degradation (ERAD) (Tyler et al., 2012; Ward et al., 1995). 
However, these proteins are not representative for the majority of NED proteins reported here 
because improper folding seems to be the mechanism behind their initial destabilization and not lack 
complex formation.  I will thereby focus the following discussion on NED of excess protein complex 
subunits. 
4.3.2.1 NED by proteins in complexes 
We found that one major mechanism behind NED is stabilization of free subunits by complex 
formation. This mode of protein stabilization was suggested already in the 1970s (Goldberg, 2003; 
Kuriyama and Omura, 1971). Examples of proteins stabilized by interactions are common e.g.: α-
spectrin (Blikstad et al., 1983), Matα2 (Johnson et al., 1998), survival of motor neuron (SMN) proteins 
(Burnett et al., 2009), RI-alpha (Amieux et al., 1997), N-methyl-D-aspartate receptor subunit 1 (Huh 
and Wenthold, 1999), Connexin 56 (Berthoud et al., 2000), tubulins (Katz et al., 1990), keratins (Kulesh 
et al., 1989), hemoglobin alpha (Shaeffer, 1988), Map2 (Okabe and Hirokawa, 1989), ribosomal 
proteins (elBaradi et al., 1986; Lam YW, 2007; Maicas et al., 1988), histones (Quivy and Almouzni, 
2003) and T cell antigen receptor subunits (Minami et al., 1987). Equally common are examples of 
proteins destabilized by the removal of its interaction partners, e.g.: PP2A subunits (Silverstein et al., 
2002), Oligosaccharyl transferase subunits (Mueller et al., 2015), nicalin-nodal modulator membrane 
complex subunits (Dettmer et al., 2010; Haffner et al., 2007), Fatty acid synthase subunit (Scazzari et 
al., 2015; Schuller et al., 1992), five friends of methylated Chtop complex subunits (Fanis et al., 2012), 
Protein subunits of the electron transportation chain (Pearce and Sherman, 1995; Stiburek et al., 
2012), APC/C complex subunits (Clark and Spector, 2015) and presenilin (Edbauer et al., 2002). 
Interestingly, most examples above come from either over expression or knock down experiments. 
Very few studies look at base line super-stoichiometric synthesis of complex subunits. The few 
exception include the T-cell receptor, the ribosome and histone 3 (Gunjan and Verreault, 2003; Lam 
YW, 2007; Minami et al., 1987; Quivy and Almouzni, 2003).  
This work is to our knowledge the first study to produce a systematic overview of steady state over 
production of complex subunits and the subsequent degradation of the non-complexed proteins. 
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4.3.2.2 Mechanisms of degradation of excess complex subunits 
It seems clear from our data and from previously published examples that the cell needs to be able to 
distinguish between complexed and free subunits and to degrade the latter with faster kinetics. The 
previously discussed N-end rule is one proposed mechanism in which a degradation signal (or 
“degron”) is hidden by interaction (Shemorry et al., 2013). Recently, a conserved mechanism for 
targeting of excess ribosomal proteins was uncovered (Sung et al., 2016). In here the yeast E3 ubiquitin 
ligase Tom1 (Huwe1 in humans) recognizes stretches of positively charged amino acids in ribosomal 
proteins that are covered in the holoenzyme. Similarly, uncomplexed histone 3 is recognized by Rad53 
which further directs the protein for degradation via the ubiquitin proteasome system (Gunjan and 
Verreault, 2003). Yet another ubiquitin ligase recognizes Fas2 when its interaction partner Fas1 in the 
fatty acid synthase is missing (Scazzari et al., 2015). In addition, multiple different chaperones work 
on unassembled proteins (Harper and Bennett, 2016). 
Another interesting example is the mitochondrial degradation pathways. This is especially true since 
we find many proteins belonging to mitochondrial inner membrane, such as members of the electron 
transportation chain among the NED proteins. Many of these proteins we found to be insensitive to 
proteasome inhibition (Supplemental table 2 and Figure 49). Proteins in the mitochondrial matrix are 
degraded by two different proteases, ClpXP and Lon, both highly homologous to their bacterial 
counterparts (Bross et al., 1995; Kang et al., 2005; Suzuki et al., 1994). In the inner mitochondrial 
membrane, the location of the electron transportation chain, no less than three independent 
proteases are located. The hetero oligomeric matrix directed m-AAA protease (m-AAA), which consists 
of paraplegin and ATPase family gene 3-like 2 (AFG3L2) and the intermembrane space pointed, i-AAA 
protease, is a homo-oligomeric complex composed of Yeast Mitochondrial escape protein 1-Like 1 
(YME1L1) (Baker and Haynes, 2011). Both the i-AAA and m-AAA are believed to function in protein 
quality control by recognizing and degrading unfolded proteins or free subunits of the electron 
transportation chain (Arlt et al., 1996; Korbel et al., 2004; Pajic et al., 1994; Stiburek et al., 2012).  In 
the inter-membrane space the homotrimeric serine protease high temperature requiredA2 (HtrA2) 
resides and degrades a number of substrates (Faccio et al., 2000; Johnson and Kaplitt, 2009). Finally, 
proteins in the outer membrane are thought to be extracted and degraded by the ubiquitin 
proteasome system in a manner partially analogous to ERAD (Baker and Haynes, 2011).     
In conclusion, many different mechanisms are involved in handling excess protein subunits, although 
the proteasome seems to play the dominant role in the cytosol and nucleus. Future work will be 
needed to untangle all the molecular pathways involved in NED in general and in NED of proteins in 
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4.3.2.3 Why are excess subunits produced only to be degraded? 
Why do we find so much NED in proteins involved in multiprotein complexes? There are multiple and 
not mutually exclusive answers to this question. The first thing to realize is that most complexes 
contain both ED and NED proteins.  
1. The first possible explanation for the excess protein synthesis is that cells are just not very 
good at coordinating the amount of protein they need. However, orthologs tend to remain ED 
or NED in different species (Figure 38) indicating that the process of becoming a NED protein 
is not fully random. In a random scenario we would expect the proteins that are NED to change 
over an evolutionary time frame.  
2. One possible explanation is that NED proteins accumulate more errors during translation or 
are harder to fold. In that case they need to be made in excess to compensate for the fact that 
many proteins never reach a functional state. We therefore looked at the differences between 
ED and NED proteins within the same complexes. We found that NED proteins on average are 
more structured and shorter. Conversely ED proteins are longer and less structured. Hence, 
mistranslation is not a likely explanation. However, misfolding of free NED subunits cannot by 
excluded as a limiting factor in the amount of available proteins to make a complex.  
3. Alternatively, NED proteins could be over-synthesized to ensure that the long and 
unstructured ED proteins always have an interaction partner and do not aggregate causing 
disease (Kim et al., 2016). Certain proteins are toxic when overexpressed (Gelperin et al., 
2005; Sopko et al., 2006). The toxicity is thought to be caused by increased amount of 
interaction-prone molecules, which increase the number of improper interactions made in a 
cell (Marcotte and Tsechansky, 2009; Vavouri et al., 2009). In multicellular organism’s 
aggregation prevention might be worth the extra energy expenditure of synthesizing proteins 
only to degrade them. In contrast, studies in E. coli have shown that bacteria produce proteins 
in well-coordinated stoichiometry (Li et al., 2014). This would indicate that single cell organism 
that do not suffer as much from aggregation related disorders coordinate the proteins levels 
without degradation of excess subunits.  
4. Another potential mechanism is that ED proteins function as rate-limiting factors in complex 
formation. The cell would then only need to upregulate the synthesis of one protein and not 
all the members of a complex to rapidly increase the levels of a complex. For example, a recent 
study demonstrated that the steady state levels of the CCT complex in different mouse strains 
could be explain by the variation of one subunit Cct6a (Chick et al., 2016). The authors 
suggested that degradation of the other super-stoichiometric CCT subunits was the most 
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probable explanation of the differences in the steady state levels of the complex. We have at 
this point only indirect evidence in support of this mechanism in the finding that ED proteins 
are more tissue-specifically expressed than NED proteins. This could mean that NED proteins 
in a complex are generally highly expressed but that ED proteins determine the tissue specific 
abundance of the final complex.  
5. The super-stoichiometric synthesis levels of NED proteins might also help complex formation 
(Marsh et al., 2013; Matalon et al., 2014; Veitia, 2016). For example, proteins with lower 
affinity interactions might need to be synthesized at higher levels for their interactions to be 
sufficiently strong. Similarly, super-stoichiometric subunits might first interact among 
themselves before they interact with lower abundant peripheral subunits and in this way 
support an ordered assembly of a complexes.    
Which, if any, of the suggested mechanism are at play we cannot say at this point. In any case, it has 
been estimated that 1 in 3 proteasomes are unengaged at steady state, meaning that cells have plenty 
of room to take care of excess, misfolded or otherwise unwanted proteins (Harper and Bennett, 2016).  
One interesting idea is that the mechanism at play is most likely not a quality control instrument. We 
have no data suggesting a qualitative difference between the NED population that gets degraded and 
the NED population that is stabilized. Not unlikely is the incorporation of a protein into a complex a 
purely random event. Therefore, the term quality control does not apply to degradation of excess 
protein subunits in contrast to, for example, the clearance of misfolded Basigin or CFTR. 
In summary, multiple mechanisms can explain why cells produce super-stoichiometric amounts of 
certain complex subunits. More research is needed to resolve which mechanism or mechanisms that 
mainly responsible. 
4.3.3 NED in aneuploidy  
Another major finding in this study is the fact that proteins defined as NED are also more likely to be 
attenuated at the protein level in aneuploid cells. The concept of attenuation was derived from studies 
of haploid yeast in which individual chromosomes were added to a disomic state (Dephoure et al., 
2014; Torres et al., 2007). It was found that transcript levels doubled with the increase in genomic 
information in the diploid yeast. However, in 20 % of cases protein levels did not follow but stabilized 
at 1.6 fold increase (Dephoure et al., 2014). This effect was most strongly seen for proteins in protein 
complexes and seemed to be dependent on protein degradation, as judged by blockage of the UPS. 
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can also be seen in human cancer cells with genomic aberrations or with artificial tri- and tetrasomies 
(Geiger et al., 2010; Stingele et al., 2012).  
Our finding that NED predicts attenuation in our triploid cells lines further extends this observation. 
First, we found that a number of proteins are “overexpressed” already at baseline, i.e. without 
chromosomal aberrations. Second, mainly the proteins that were super-stoichiometrically produced 
to begin with were attenuated in the triploid cell line (Figure 44). That means that belonging to a 
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5 Outlook 
5.1 Potential impact of the work 
Hopefully, this work will dispel the common assumption of exponential degradation of proteins. This 
assumption is frequently applied to degradation modelling, e.g. Schwanhäusser et al. (2011). An 
exponential model will fit data based on degradation of a steady state (i.e. not age-defined) population 
without too much error because most NED proteins at steady state occur only in the second state and are 
therefore mainly impacted by the second degradation rate (Figure 50). However, an exponential model 
severely underestimates the importance of protein degradation in establishing the proteome. Only when 
applying more careful kinetic measurements such as AHA p-c the full impact of degradation on the 
proteome can be understood. For example, the apparent poor correlation between transcript and protein 
abundances could potentially improve if one took into account the initial degradation rate of NED proteins 
(Vogel and Marcotte, 2012). E.g. NED could be responsible for cases of lower than expected protein 
abundance based on transcript levels.  
Importantly, the method described here should be applicable in answering many open questions in the 
field (see below). One particular area where AHA p-c should allow important progress is in the functional 
definition of different chaperones, E3 ubiquitin ligases and proteases involved in protein quality control 
and removal of excess protein subunits. For example, one could perform a knock-out screen of potential 
PQC proteins in combination with AHA p-c to look for substrates with increased NED. 
Finally, the implication of NED proteins in establishing the steady state proteome during aneuploidy 
should increase the understanding of disease phenotypes in developmental syndromes and cancers 
depending on large genetic alterations.  
5.1.1 Open questions 
This work generates many questions. For example:  
 Orthologs display similar degradation kinetics in different species, which strongly points to a 
biological function of NED. In addition, differences in molecular features between ED and NED 
proteins further indicates functionality. However, the question why proteins are NED is still open 
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 Two pools of NED proteins exist with one having a higher degradation rate than the other. How 
does the cell distinguish between the two?  
o Are uncovered “degrons” such as N-terminal acetylation or stretches of positively 
charged amino acids responsible for the recognition of all uncomplexed subunits?  
o Furthermore, which are the folding-factors, ubiquitin ligases and proteases 
involved? Of particular interest are the mitochondrial proteases since a 
substantial fraction of NED proteins reside in mitochondria and do not respond 
proteasome inhibition (Figure 49).  
 What is the function of ED proteins in complexes?  
o Are they rate limiting subunits? Would increasing their abundance increase 
steady state levels of their respective complexes?  
o Are ED proteins “toxic” when overexpressed? Do NED protein function as 
chaperones for ED proteins? 
 What is the role of NED in buffering differences in transcript levels between different species, 
organs and in diseases? For example, it is known that most of the genetic and transcriptome 
differences between humans and chimps are buffered at the protein levels (Khan et al., 2013). To 
what extent is NED responsible for these kinds of observations? Studies looking at protein 
quantitative trait locis (pQTLs) indicate that post translational mechanisms are indeed responsible 
for much of the transcriptome buffering (Battle et al., 2015; Chick et al., 2016).  
 How detrimental are NED proteins for cells during Aneuploidy?  
o Does the fact that excess NED proteins are not lingering in cells make them less 
harmful than ED protein that accumulate? The fact that “overexpression” of 
individual toxic protein in aneuploidy does not seem to cause disease would 
argue against ED proteins as the main driver of disease phenotype (Donnelly and 
Storchová, 2014; Torres et al., 2007). 
o Alternatively, is the extra burden on the cellular PQC systems by the extra NED 
proteins destined for degradation one of the drivers of disease phenotypes? 
General PQC stress in aneuploidy implicates NED proteins in aneuploidy related 
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6 Supplementary Information 
6.1 Abbreviations 
Abbreviation  Expansion 
ABC  Ammonium BiCarbonate 
AHA  L-Azidohomoalanine 
AIC  Akaike Information Criterion 
ATP  Adenosine Triphosphate 
AUC  Area Under the Curve 
CFTR  Cystic Fibrosis Transmembrane Conductance Regulator 
DAPI  4',6-Diamidino-2-Phenylindole 
dFCS  dialyzed Fetal Calf Serum 
DMEM  Dulbecco’s Modified Eagle's Medium 
DNA  Deoxyribonucleic Acid 
DRiPs  Defective Ribosomal Products 
DTT  Dithiothreitol 
ED  Exponentially Degraded 
EDTA  Ethylenediaminetetraacetic acid 
ER   Endoplasmic Reticulum 
ERAD  Endoplasmic Reticulum- Associated Protein Degradation 
ESI  Electrospray Ionization 
FITC  Fluorescein Isothiocyanate 
HPLC  High-Performance Liquid Chromatography 
iBAQ  Intensity Based Absolute Quantification 
LC-MS/MS  Liquid Chromatography Tandem Mass Spectrometry 
LDS  Lithium Dodecyl Sulfate 
LSD  Lowest Score Deviation 
LTQ  Linear Ion Trap Quadrupole 
LysC  Lysyl Endopeptidase 
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Met  Methionine 
MHC-I  Major Histocompatibility Complex I 
MPI  Max Planck Institute 
NED  Non-Exponentially Degraded 
PBS  Phosphate-Buffered Saline 
p-c   Pulse-Chase 
PQC  Protein Quality Control 
RNA  Ribonucleic Acid 
ROC  Receiver Operating Characteristics 
rRNA  Ribosomal Ribonucleic Acid 
SAX  Strong Anion Exchange 
SCX  Strong Cation Exchange 
SILAC  Stable Isotope Labeling by Amino Acids in Cell Culture 
StageTip  Stop and Go Extraction Tip 
TAMRA  5-Carboxytetramethylrhodamine 
TCR  T-Cell Receptor 
TFA  Triflouroacetic Acid 
Tris  Tris(hydroxymethyl)aminomethane 
tRNA  Transfer Ribonucleic Acid 
UN  Undefined 
UPS  Ubiquitin proteasome system 
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6.2 Supplementary figures 
 
Figure 48. SILAC pulse-chase experiments as in Figure 27. 
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Figure 49. NED proteins insensitive to proteasome inhibition are enriched for mitochondrial proteins. 
Taking the 20 % of NED proteins with the smallest response to MG132 in Figure 29 B (n = 47) and looking 
for enrichment of the GO-terms subcategory subcellular location using the DAVID tool (Huang et al., 2009) 
we found an enrichment for proteins in the mitochondrial inner membrane using all NED proteins in Figure 
29 B as background (n = 236). The fold enrichment of the two most significant hits are displayed. p-values 
are based on a modified Fisher exact test and have been corrected for multiple hypothesis testing using 
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Figure 50. Distribution of NED proteins between state A and B at steady state. 
Histogram showing the % of NED proteins in state A at steady state. All NED proteins are mainly in the 
second state at steady state. 74 % of NED proteins have less than 5 % of molecules in state A at steady 
state. That would mean that, at steady state, most NED proteins that are stabilized by complex formation 
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6.3 Supplementary tables 
Supplemental tables 1-5 can be downloaded from: 
http://www.cell.com/action/showImagesData?pii=S0092-8674%2816%2931248-X  
 
6.4 Raw-data access  
6.4.1 Mass spectrometric data 
Mass spectrometric data has been uploaded to the ProteomeXchange data base with the following 
accession (Vizcaíno et al., 2014): 
Mouse:  PXD004929 
Human: PXD004915  
6.4.2 Genomic sequencing data  
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